The QualityStocks Daily Monday, January 29th, 2024

Today's Top 3 Investment Newsletters

The Street(PALI) $0.9600 +84.62%

QualityStocks(KGKG) $0.0033 +57.14%

RedChip(RVSN) $14.6900 +54.63%

The QualityStocks Daily Stock List

Palisade Bio Inc. (PALI)

QualityStocks, MarketBeat, Penny Pick Finders, Buzz Stocks, HotOTC, InvestorsUnderground, Mega Stock Alerts, 360wallstreet, OTCtipReporter, The Stock Dork, PennyStockProphet, PennyStockScholar, Profitable Trader Authority, StockOnion, The Online Investor and Money Wealth Matters reported earlier on Palisade Bio Inc. (PALI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Palisade Bio Inc. (NASDAQ: PALI) (FRA: 7NSA) is a clinical stage biopharmaceutical firm that is focused on the discovery, development and commercialization of oral therapies which target severe ailments linked to the breakdown of the mucosal barrier that protects the gastrointestinal tract.

The firm has its headquarters in Carlsbad, California and was incorporated in 2005. Prior to its name change, the firm was known as Seneca Biopharma Inc. It serves consumers around the globe.

The company develops therapies which help patients with chronic and acute gastrointestinal complications which were caused by post-operative digestive enzyme damage. Its mission is to develop new treatments for diseases with unmet medical needs. The company is in the process of finding and acquiring new assets, promising technologies and sciences which will provide meaningful therapies to patients.

The enterprise’s product portfolio comprises of a phase III-ready oral liquid serine protease formulation, a digestive enzyme inhibitor dubbed LB1148, which has been designed to preserve gut integrity during intestinal stress and hinder digestive enzyme activity by neutralizing digestive proteases released from the gut during an operation. Intestinal stress may be caused by surgery, inflammatory conditions, infections and decreased blood flow to the intestine. The formulation was also developed to help restore bowel function following an operation.

The firm’s LB1148 formulation was recently granted a new patent for its use in the treatment of post-operative ileus and adhesions. This is a major milestone for the firm, which is focused on advancing its clinical pipeline and providing more data that will support the formulation’s approval for use by patients.

Palisade Bio Inc. (PALI), closed Monday's trading session at $0.96, up 84.6154%, on 136,020,287 volume. The average volume for the last 3 months is 27.257M and the stock's 52-week low/high is $0.50/$3.65.

Kona Gold Beverage (KGKG)

QualityStocks and MarketClub Analysis reported earlier on Kona Gold Beverage (KGKG), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Kona Gold Beverage Inc. (OTCQB: KGKG) is a lifestyle hemp firm that is focused on the development and sale of CBD (cannabidiol) and hemp products in the functional fitness and beverage markets.

The firm has its headquarters in Melbourne, Florida and was incorporated in March 1997. Prior to its name change, the firm was known as Kona Gold Solutions Inc. It operates through the drug manufacturers-specialty and generic industry, under the healthcare sector. The firm mainly serves consumers in the United States.

The enterprise operates through the Beverage and Distribution segments. The former segment includes different types of beverage products, including CBD-infused high-alkaline water, CBD-infused energy water, hemp-infused energy drinks and lemon-flavored beverages, as well as merchandise and apparel with the Kona Gold logo, which includes towels, shirts, hats and tanks. This segment includes all of its Ooh La Lemin, HighDrate and Kona operations. On the other hand, the latter segment is involved in the distribution of premium beverages and snacks in key markets. The distribution segment comprises of all of the enterprise’s operations. The enterprise also distributes CBD-infused jellybeans, healthy aloe juice drinks, fruit-flavored sodas, energy drinks, beverages for children and alkaline waters. It sells its products primarily to beverage resellers and distributors, smoke shops, retail grocery shops, specialty stores, vape shops, convenience stores, merchandisers and wholesalers.

The company’s lemonade drinks will soon begin to be sold at Walmart, according to a recent announcement. This move will help take its brand portfolio national, in addition to bringing in significant revenues and extending its consumer reach.

Kona Gold Beverage (KGKG), closed Monday's trading session at $0.0033, up 57.1429%, on 52,191,979 volume. The average volume for the last 3 months is 416,465 and the stock's 52-week low/high is $0.0002/$0.0075.

MAIA Biotechnology (MAIA)

FreeRealTime, bullseyeoptiontrading and MarketClub Analysis reported earlier on MAIA Biotechnology (MAIA), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

MAIA Biotechnology Inc. (NYSE American: MAIA) is a clinical-stage biotechnology firm focused on discovering, developing and commercializing potential first-in-class drugs with new mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer.

The firm has its headquarters in Chicago, Illinois and was incorporated in 2018, on August 3rd. It operates as part of the biotechnology industry, under the healthcare sector, oncology division. The firm serves consumers across the globe.

The enterprise’s pipeline is comprised of several targeted immuno-oncology therapies for difficult-to-treat cancers. The enterprise's THIO (6-thio-dG, 6-thio-2’-deoxyguanosine) is a potentially first-in-class small molecule that is a telomere-targeting agent in clinical development. Telomerase is present in >85% of human cancers and contributes greatly to the proliferation and reproductive immortality of cancer cells.THIO is followed by Libtayo for the treatment of advanced non-small-cell lung cancer. The enterprise is advancing THIO in Phase II clinical study in Non-Small Cell Lung Cancer. Its second-generation program is focused on the discovery of new compounds with potentially improved specificity towards cancer cells relative to normal cells and with potentially increased anticancer activity. The second-generation pipeline of potential telomere-targeting agents includes five compounds that have undergone in-vitro inhibitory testing in five cancer models.

The company recently announced that the World Intellectual Property Organization had published its global Patent Cooperation Treaty application on compounds that are key next-generation telomere-targeting agents, an important extension of the company’s innovative cancer treatment platform. This move may open the company up to new growth and investment opportunities.

MAIA Biotechnology (MAIA), closed Monday's trading session at $1.47, up 8.8889%, on 216,583 volume. The average volume for the last 3 months is 15,337 and the stock's 52-week low/high is $0.82/$5.22.

Roadzen (RDZN)

We reported earlier on Roadzen (RDZN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Roadzen Inc. (NASDAQ: RDZN) (NASDAQ: RDZNW) is an insurance technology firm that is engaged in the provision of online on-demand roadside assistance services with a network of towing and roadside repair providers in India.

The firm has its headquarters in New Delhi, India and was incorporated in 2015. It operates as part of the software-application industry, under the technology sector. The firm serves consumers in India.

The enterprise’s technology is used by different clients to build new products, sell insurance, process claims and improve road safety. These clients include fleets, insurers, carmakers, brokers, small fleets, and insurance agents. Its products include SurePrice, Mantis Telematics Platform, VIA, xClaim, and StrandD. SurePrice is an end-to-end portfolio management platform while Mantis Telematics Platform provides 360 contextual driver risk assessment for UBI/BBI along with accident prevention and fleet management solutions to suit requirements of all varieties of private and commercial vehicles and drivers. VIA evaluates the value of a vehicle through inspection in record time while xClaim is an end-to-end claims management platform that allows insurers to fast-track motor claim processing. On the other hand, StrandD is an RSA management platform that helps log, track and manage assistance services while offering timely service updates to customers.

The company recently partnered with HCLTech, an international tech firm, to deliver AI-driven auto insurance solutions for carriers in the United States as well as their automotive customers. This move may open the company up to new growth and investment opportunities that will drive shareholder value. This is in addition to extending its consumer reach globally.

Roadzen (RDZN), closed Monday's trading session at $5.39, up 1.6981%, on 8,032 volume. The average volume for the last 3 months is 125,619 and the stock's 52-week low/high is $2.70/$17.00.

Aluminum Corp of China (ALMMF)

We reported earlier on Aluminum Corp of China (ALMMF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Aluminum Corporation of China Limited (OTC: ALMMF) (HKG: 2600) (SHA: 601600) (FRA: A0C) is a company focused on exploring for and mining coal, bauxite, and other resources.

The firm has its headquarters in Beijing, China and was incorporated in 2001, on September 10th. It operates as part of the aluminum industry, under the basic materials sector. The firm serves consumers around the globe, with a focus on those in the People’s Republic of China.

The enterprise operates through the Primary Aluminum; Alumina; Energy; Trading; and Corporate and Other Operating segments. The Primary Aluminum segment procures alumina and other raw materials, supplemental materials, and electrical power; and produces and sells aluminum and aluminum-related products, such as carbon, aluminum alloy, and other electrolytic aluminum products. The Alumina segment mines for and purchases bauxite and other raw materials; refines bauxite into alumina; and sells alumina, as well as produces and sells refined alumina, gallium, and multi-form alumina bauxite. The Energy segment generates and sells electricity using thermal, wind, and solar power sources to regional power grid corporations; mines for coal deposits; and manufactures power-related equipment. The Trading segment trades in alumina, primary aluminum, aluminum fabrication products, other non-ferrous metal products, coal products, and raw and supplemental materials; and offers logistics and transport services to external customers. The Corporate and Other Operating segment offers research and development services; and operates other aluminum-related business activities. The enterprise also acquires, manufactures, and distributes bauxite mines and limestone ore; and offers engineering project management, as well as engages in import and export activities.

The company remains committed to generating additional value for its shareholders.

Aluminum Corp of China (ALMMF), closed Monday's trading session at $0.4601, off by 0.195228%, on 5,000 volume. The average volume for the last 3 months is 113,113 and the stock's 52-week low/high is $0.389/$0.6088.

Turnstone Biologics (TSBX)

MarketBeat reported earlier on Turnstone Biologics (TSBX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Turnstone Biologics Corp. (NASDAQ: TSBX) is a clinical-stage biotechnology firm that is focused on the development of a disruptive class of engineered viral immunotherapies and medicines designed to fight malignant disease at multiple points of intervention.

The firm has its headquarters in La Jolla, California and was incorporated in 2014. It operates as part of the biotechnology industry, under the healthcare sector. The firm serves consumers in the United States.

The company is pioneering a differentiated approach to tumor-infiltrating lymphocytes, or TILs, a clinically validated technology for treating solid tumors. Its tumor infiltrating lymphocytes (TIL) therapies are designed to drive clinical benefit and curative outcomes across multiple solid tumors. Its selected TIL approach focuses on selecting and expanding potent tumor-reactive T cells to overcome the limitations of bulk TILs. The company’s pipeline includes TIDAL-01 and TIDAL-02. Its lead selected TIL product candidate, TIDAL-01, uses an unbiased identification and functional screening process to isolate and selectively expand the breadth of tumor-reactive TILs from the patient’s tumor. Its next selected TIL program, TIDAL-02, is being designed to encompass a streamlined manufacturing process for tumor-reactive T cells and additional modifications to enhance TIL quality and function. The company’s proprietary vaccinia virus platform has been engineered to stimulate the immune system, drive antigen presentation and recognition, and re-shape the tumor microenvironment.

The firm remains focused on its mission to develop new medicines to treat and cure patients with solid tumors. Their success will greatly benefit patients with a range of cancers while also encouraging additional investments into the firm.

Turnstone Biologics (TSBX), closed Monday's trading session at $2.55, off by 7.2727%, on 67,677 volume. The average volume for the last 3 months is 100,884 and the stock's 52-week low/high is $1.625/$13.20.

Brunswick Exploration (BRWXF)

We reported earlier on Brunswick Exploration (BRWXF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Brunswick Exploration Inc. (OTCQB: BRWXF) (CVE: BRW) is a junior exploration and evaluation firm focused on acquiring, exploring for and evaluating mining property assets in Canada for metals necessary for decarbonization and energy transition, with a particular focus on lithium, tin, nickel and copper.

The firm has its headquarters in Montreal, Canada and was incorporated in 2007, on June 20th. It operates as part of the gold industry, under the basic materials sector. The firm serves consumers primarily in Canada.

The company primarily explores for lithium in Eastern Canada. It owns interests in mining claims, which are located in Quebec, Saskatchewan, Ontario, Newfoundland, New Brunswick, Manitoba, and Nova Scotia. Its Quebec projects include the James Bay Lithium project, North Shore Lithium project, Pontiac Lithium project, and Mirage project. Its Ontario project is the Hearst project while itsAtlantic Canada projects include the SMB project (Nova Scotia), Catamaran project (New Brunswick), and Newfoundland project. The company’s Prairie Projects include the Hanson Lake project, Trans-Hudson, Lake Athabaska project and Lynn Lake project. Its Pontiac Lithium Project is located in the Pontiac geological province, south of the Cadillac-Larder Lake break, and is accessible by road from Rouyn-Noranda, Malartic. The project covers roughly 618 claims.

The firm, which recently commenced its phase II drilling campaign at the Mirage project located in the Eeyou-Istchee James Bay region, is focused on advancing its exploration efforts at its projects. Successful efforts may bring in additional revenues into the firm while also creating value for its shareholders.

Brunswick Exploration (BRWXF), closed Monday's trading session at $0.4076, up 7.2632%, on 17,030 volume. The average volume for the last 3 months is 345,331 and the stock's 52-week low/high is $0.35/$0.87.

Verano Holdings Corp. (VRNOF)

QualityStocks, MarketBeat, InvestorPlace, The Street and Early Bird reported earlier on Verano Holdings Corp. (VRNOF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

A recent federal study conducted by the Centers for Disease Control and Prevention (CDC) has shown a notable decline in cannabis use among teenagers in King County, Washington State’s largest county, following recreational use legalization in 2012. The study indicates a substantial decrease in both frequent and current cannabis use among 8th, 10th, and 12th-grade students, according to data from 2008 to 2021.

According to researchers, the legalization of marijuana combined with related rules and age restrictions may have made it less available to minors. They do, however, concede that the COVID-19 epidemic may have contributed to more recent drops in use.

Using youth survey data from the state’s health department, researchers found that “current cannabis use,” defined as use within a one-month time frame, decreased significantly from peak levels of 15.5% in 2012 to 9% in 2021 for females and 20.4%in 2010 to 7.7% in 2021 for males.

Although the trend of reduced teen-use rates started soon after the legalization of recreational cannabis, according to the study’s authors, the COVID-19 pandemic, which resulted in the imposition of stay-at-home regulations in March 2020, may have exacerbated the decline in recent years.

Since peak usage in 2012, there has been a steady decline in teen use of cannabis. For instance, the percentage of males who used the substance frequently, meaning more than six days a month, decreased from 7.5% in 2014 to 3.7% in 2021. Though usage among female students declined as well, it did so more gradually, with rates dropping from 15.5% in 2012 to 9% in 2021.

Interestingly, 2021 was the only year where female users had a slightly higher prevalence of current use. Nonetheless, male users still reported more frequent use compared to their female counterparts.

According to the study, there has been a noticeable decline in the gender gap in recent cannabis use prevalence rates. Although the study hypothesized that changing societal norms surrounding marijuana could be connected to gender variations in marijuana use, the authors urged further research to look at cannabis-use patterns related to gender and norms.

These results are consistent with another study conducted on high school students in Canada, which found that once marijuana was legalized, most felt that it was less accessible. The study authors attributed the outcome to both national legalization and COVID-19 social-distancing measures. Additionally, another CDC analysis also showed a decline in high school students’ marijuana use after legalization in most states.

Such research findings don’t support prohibitionists who argue that ending cannabis prohibition by allowing such as Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) to operate would result in skyrocketing teen access to the drug.

Verano Holdings Corp. (VRNOF), closed Monday's trading session at $6.04, up 1.1725%, on 148,232 volume. The average volume for the last 3 months is 8.052M and the stock's 52-week low/high is $2.53/$6.07.

Bit Digital Inc. (BTBT)

QualityStocks, StocksEarning, MarketClub Analysis, Schaeffer's, TradersPro, InvestorPlace, Wealth Daily, StockEarnings, MarketBeat, InvestorsUnderground, Daily Trade Alert and CryptoCurrencyWire reported earlier on Bit Digital Inc. (BTBT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Despite the prohibition of cryptocurrency trading in 2021 by the Chinese government, reports indicate an active black market in the country. According to a Wall Street Journal (WSJ) article, investors are navigating the stringent regulations through informal networks, utilizing social media, VPNs and in-person trading.

China is a region that has some of the strictest regulations in the world regarding cryptocurrency trading, with authorities vigorously pursuing those involved in the sector. Perpetrators face the threat of arrest, penalties or jail time. But according to the WSJ, some Chinese dealers have not been deterred by these actions. Additionally, Ben Gagnon, chief mining officer of Bitfarms, noted that energy-capture technologies in Chinese residential dwellings have enabled a quiet comeback to cryptocurrency mining in the country.

Citing an October report from Chainalysis, the WSJ revealed that Chinese traders made a net profit of $86 billion from cryptocurrency transactions between July 2022 and June 2023. Further, an estimated $90 billion was traded on Binance per month on average.

Reportedly, Chinese traders are still able to access accounts on foreign cryptocurrency exchanges that were created before the ban by using VPNs to mask IP addresses and get around georestrictions. Furthermore, peer-to-peer cryptocurrency trading is purportedly conducted on social media sites such as Telegram and WeChat. Traders can locate sellers and buyers on the platforms by joining specific groups, thus eliminating the need for crypto exchanges.

In-person trading is also widespread, especially in inland areas such as Yunnan and Chengdu, where enforcement is more lenient. Traders frequently gather together in public places such as laundromats or cafes to swap cryptocurrency wallet addresses and carry out bank or cash transfer transactions.

Additionally, traders are taking advantage of Hong Kong’s welcoming attitude toward digital assets by depositing funds into cryptocurrency accounts there using their annual quotas of $50,000 for foreign exchange purchases. Some observers surmise that officials, aware of the market’s considerable potential for disruption as well as its substantial opportunities, deliberately encourage cryptocurrency trading in Hong Kong as a trial run for any changes in the government’s stance on digital assets.

Despite its past as a major center for cryptocurrency trade and mining, China continues to have a strong position against cryptocurrencies. The nation supports blockchain technology when it comes to livestock tracking, digital IDs and luxury product authentication, but it is more interested in private blockchains than in the decentralized ledgers that are common in web3.

The environment surrounding crypto trading is constantly changing as Chinese investors continue to flout the ban. The idea that China’s participation in the cryptocurrency industry has decreased as a result of the prohibition is called into question by the tenacity of investors, innovative tactics and a developing market in Hong Kong.

The tenacity of the traders in China shows how much people around the world are coming to appreciate the benefits they can reap from working with industry companies, such as Bit Digital Inc. (NASDAQ: BTBT).

Bit Digital Inc. (BTBT), closed Monday's trading session at $2.95, up 5.3571%, on 7,295,490 volume. The average volume for the last 3 months is 595,190 and the stock's 52-week low/high is $0.9707/$5.27.

Compass Pathways PLC (CMPS)

InvestorBrandNetwork, QualityStocks, InvestorPlace, MarketBeat, Daily Trade Alert, Top Pros' Top Picks, StreetInsider, Schaeffer's, Trades Of The Day, The Street and Prism MarketView reported earlier on Compass Pathways PLC (CMPS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

The European Union (EU) is funding research into psychedelic-based therapies for patients with incurable diseases. Researchers will use EU funding to determine if psychedelic drugs such as psilocybin can help alleviate psychologic distress in palliative-care patients.

While palliative and end-of-life care are designed to relieve physical symptoms and make patients as comfortable as possible, there aren’t a lot of protocols to alleviate the psychological distress that often accompanies incurable illnesses. Psychedelics have exhibited significant potential as mental-health treatments in several initial studies and have shown that they can treat significant mental distress in conditions such as depression and post-traumatic stress disorder (PTSD) with few if any side effects.

EU scientists are already working on a clinical trial studying the impacts of psilocybin, the main psychoactive agent in magic mushrooms, against atypical Parkinson’s disease, multiple sclerosis, chronic obstructive pulmonary disease and amyotrophic lateral sclerosis. The EU-funded research will feature a much wider cohort of patients than previous studies to determine if psychedelics can relieve hard-to-treat depression in people with terminal conditions. This will be the first time the European Union provides full funding (more than $7 million) for a psychedelic study. The European Union will award the funding through its Horizon Europe Program.

The study will involve treating 100 patients in four sites in Portugal, the Netherlands, Denmark and the Czech Republic under the coordination of the Netherlands’ University Medical Center Groningen (UMOG). Study participants will take part in several therapy sessions and receive two doses of psilocybin starting with a lower dose followed by a higher one; some participants will receive a placebo. Unlike the majority of prior psychedelic studies, the EU-funded trial will use two doses of psilocybin instead of a single dose.

In this case, the initial smaller dose is to help patients become accustomed to the psychedelic experience before they receive the larger doses.

UMCG psychiatrist and lead investigator Robert Schoevers says the number of psychedelic trips required for the treatment to be effective is one of the major questions in the nascent psychedelic research field. He said that the researchers would explore whether a single dose followed by psychotherapy is sufficient for long-term relief.

Past studies have found that only one dose can offer respite against numerous symptoms of poor mental health, especially when the treatment is accompanied by psychotherapy. On the other hand, conventional mental-health treatments such as antidepressants usually require daily use over several weeks or even months to be fully effective, and they often cause moderate to severe side effects.

The research team will partner with health-technology assessment bodies and regulators to draw up the study protocol before beginning the trial in January 2025 and issuing its findings sometime in 2027.

The findings of this study will add onto the body of scientific data that psychedelic companies such as Compass Pathways PLC (NASDAQ: CMPS) have uncovered in their different R&D activities.

Compass Pathways PLC (CMPS), closed Monday's trading session at $11.48, up 7.3901%, on 1,373,741 volume. The average volume for the last 3 months is 178,886 and the stock's 52-week low/high is $5.01/$11.5386.

Cenntro Electric Group Inc. (CENN)

QualityStocks, GreenCarStocks, TradersPro, Penny Stock and InvestorPlace reported earlier on Cenntro Electric Group Inc. (CENN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Toyota boss Akio Toyoda says electric vehicles will never dominate the global market. According to the executive, battery electric vehicles (BEVs) will not exceed 30% of the market share even if consumers adopt the alternative energy vehicles in mass.

Although Toyota was the first automaker to develop and sell alternative-energy vehicles, the Japanese company hasn’t been keen on adopting BEVs. It is the only established carmaker that hasn’t manufactured or planned to manufacture a fully electric vehicle; the company has instead placed all its bets on hydrogen-fuel-cell vehicles.

Toyoda explained that while electric vehicles still had a place in global transportation, petrol vehicles, hybrids and hydrogen fuel cells would dominate the market. The executive noted that with hundreds of millions of people still living with no access to electricity, EVs couldn’t be the future of transportation.

According to data from Statista, around one billion people around the world live with no electricity. The Toyota executive said the company is exploring various options to serve people living in regions where charging an electric car is not possible. At most, he said, EVs will account for 30% of the market share and will not dethrone combustion engine vehicles as the main form of vehicular transportation.

Toyoda said that the decision to transition to electric cars should be made by customers, not politics or regulations. Unlike other established automakers, Toyota has repeatedly defied pressure from governments and NGOs to follow accelerated electrification timelines. This also isn’t the first time Toyoda has spoken out against the global push to electrify transportation over the next couple of decades. In October 2023, the executive attended an auto show in Japan and said electric vehicles weren’t the silver bullet against carbon-dioxide emissions.

Proponents of electrification say battery electric cars are key to reducing emissions in the transportation sector. The absence of an internal combustion engine cuts their tailpipe emissions to zero and makes them suitable for a carbon-neutral economy. However, the high prices of EVs have prevented most drivers from making the switch from fossil-fuel vehicles to electric cars. Most countries’ electric grids don’t have the capacity to power massive EV fleets, and many experts say the world’s supply of EV battery metals may not be able to support mass electric-vehicle adoption.

Electric-vehicle demand has also fallen in recent months. Many automakers are now cutting back on their previously ambitious electrification plans because of falling prices and low demand. Industry actors, such as Cenntro Electric Group Inc. (NASDAQ: CENN), are now probably engaged in seeking ways to make more sales amid high interest rates and falling demand.

Cenntro Electric Group Inc. (CENN), closed Monday's trading session at $1.26, up 3.2787%, on 133,675 volume. The average volume for the last 3 months is 19.686M and the stock's 52-week low/high is $1.00/$8.71.

Tilray Brands Inc. (TLRY)

InvestorPlace, Schaeffer's, StocksEarning, The Street, StockEarnings, QualityStocks, MarketClub Analysis, MarketBeat, Trades Of The Day, Daily Trade Alert, StockMarketWatch, Kiplinger Today, StreetInsider, The Online Investor, Wealth Insider Alert, Market Intelligence Center Alert, BUYINS.NET, Zacks, Investopedia, CFN Media Group, CNBC Breaking News, Early Bird, The Street Report, Daily Profit, INO Market Report, StreetAuthority Daily, Inside Trading, The Rich Investor, Trading Concepts, Trading For Keeps, Tip.us, FreeRealTime, Top Pros' Top Picks, InvestmentHouse, InsiderTrades, Eagle Financial Publications, Investors Alley, Investment House, Outsider Club, wyatt research newsletter, Wealth Daily, VectorVest, TheTradingReport, The Night Owl, StrategicTechInvestor, MarketClub, Rick Saddler, InvestorsObserver Team, Money Morning, AllPennyStocks, Marketbeat.com, Louis Navellier, Jim Cramer, Jason Bond, InvestorsUnderground and Stock Up Featured reported earlier on Tilray Brands Inc. (TLRY), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Missouri voters approved a recreational cannabis measure in 2022, joining the growing number of states with adult-use marijuana markets. However, the legalization measure did not address how employers would handle compensation for employees who sustain workplace injuries while under the influence of cannabis.

Currently, employees may have their compensation and death benefits cut by up to 50% even if they hadn’t consumed cannabis for days but still tested positive for THC. This mostly stems from the fact that existing cannabis tests aren’t accurate and cannot properly connect blood THC levels to actual intoxication. Worker compensation attorney Bradley Young says this hasn’t changed even after voters legalized recreational marijuana because cannabis is still prohibited at the federal level.

Republican Representatives Sherri Gallick and John Voss have introduced measures that would add cannabis to the state’s workers’ compensation law. Under Missouri’s workers’ current compensation law, employees whose on-the-job injuries are sustained “in conjunction with nonprescribed controlled drugs” face a 50% reduction of their benefits.

According to Young, Missouri state law currently doesn’t classify marijuana as a nonprescribed controlled drug despite its status at the federal level.

Gallick’s bill would exempt medical cannabis patients who were using cannabis with a physician’s prescription while Voss’s measure does not include similar language. Another measure introduced by Jefferson City Republican Senator Mike Bernskoetter also mirrored the language in Voss’s bill.

However, both measures have faced opposition from Democrats and Republicans on the House Insurance Policy Committee. Republican Representative Richard West noted that his biggest problem with the measure is that the technology to accurately measure marijuana impairment doesn’t exist. He noted that employees can still lose 50% of their benefits if they have some cannabis in their systems from prior use but aren’t impaired during a workplace injury under the bill.

Young argued that after serving as a workers’ compensation defense attorney for three decades, he had never seen a case where a judge cut a worker’s benefits for using cannabis weeks, or even days, after the injury.

Several lawmakers criticized existing testing methods for their inaccuracy in properly measuring cannabis impairment. Most cannabis tests will show positive results even if an individual consumed marijuana several hours or even days prior and isn’t impaired at the moment of testing.

Conversely, alcohol impairment tests are incredibly effective at measuring intoxication levels on the spot. Without accurate cannabis impairment testing technology, West wondered whether the state would have to prevent people from consuming a legal substance in their free time.

When asked when efficient cannabis-testing technology will be available, Young said he represents a company that bought technology to determine if THC is active at the moment of testing. The technology is currently expensive, but Young said it would be more affordable next year.

The discussions in Missouri show that despite the existence of regulated markets in different states and countries where companies such as Tilray Brands Inc. (NASDAQ: TLRY) (TSX: TLRY) operate, many reforms still need to be considered to end manifestations of prohibition.

Tilray Brands Inc. (TLRY), closed Monday's trading session at $1.96, up 2.6178%, on 17,246,012 volume. The average volume for the last 3 months is 34,754 and the stock's 52-week low/high is $1.50/$3.59.

The QualityStocks Company Corner

First Tellurium Corp. (CSE: FTEL) (OTCQB: FSTTF)

The QualityStocks Daily Newsletter would like to spotlight First Tellurium Corp. (CSE: FTEL) (OTCQB: FSTTF) .

Funds have begun adopting increasingly bearish stances on copper as the market reels from the sudden loss of 600,000 tons of expected copper supply. Most experts and the copper market itself expected to produce a surplus of copper in 2024, but the unexpected loss of more than one-half a million tons of copper supply threw the market into a sudden deficit. In late 2023, the Panama government instructed a Canadian mining and metals company to shut down its lucrative Cobre Panama copper mine after the country's Supreme Court invalidated its operating license. The mine was responsible for 1% of the world's copper supply and produced 350,000 tons of copper annually. In addition, London-based miner Anglo American cut its 2024 production target for copper from up to a million tons to 730,000–790,000 tons, depriving the supply chain of around 200,000 tons of copper. Exploration companies such as First Tellurium Corp. (CSE: FTEL) (OTCQB: FSTTF) are likely to be key in bringing to market new supplies of copper to address the looming shortage in the years and decades to come.

First Tellurium Corp. (CSE: FTEL) (OTCQB: FSTTF) is committed to exploring for and providing essential and critical metals, including tellurium, gold, silver, copper and tungsten, for North American markets. This objective is anchored by the company’s Deer Horn tellurium-gold-silver-copper project in British Columbia, Canada, and further enhanced by its property option on the Klondike tellurium-gold prospect located in Colorado, USA.

First Tellurium’s unique business model is to generate revenue and value through mineral discovery, project development, project generation and cooperative access to untapped mineral regions in indigenous territory with sustainable exploration potential.

The company is headquartered in Vancouver, British Columbia.

Tellurium and the Green Energy Revolution

Tellurium has a key role to play in the ongoing green energy revolution. It is widely used in the manufacturing of photovoltaic cells for solar panels.

Despite this utility, ongoing trade tensions between China and the U.S. create implications for both tellurium and the production of cadmium-tellurium solar cells. Earlier this year, China announced plans to restrict exports of critical metals gallium and germanium, both essential for the production of semiconductors. For reference, China produces around 80% of the world’s gallium and approximately 60% of the world’s germanium.

China’s recent trade restrictions amplify the fragility of the North American tellurium supply, as the Asian nation currently produces about 60% of the world’s tellurium. This sustained supply vulnerability is why First Solar, the United States’ largest solar panel producer, set up a worldwide search for tellurium deposits in the mid-2000s.

“In North America alone, our understanding is that First Solar looked at over a hundred tellurium properties,” First Tellurium CEO Tyrone Docherty stated in a news release. “Their number one property by far, which they acquired, was the Colorado Klondike which we now control.”

The U.S. is now looking to secure safe, domestic sources of tellurium and many other critical metals to pre-empt potential shortages. The Biden administration has instituted a stream of policies, particularly the U.S. Inflation Reduction Act, to source solar components from North America and other “friendly” jurisdictions.

As the only junior mining company in the world focused on tellurium exploration, First Tellurium is ahead of the curve in capitalizing on these initiatives to establish strategic, domestic supplies of key resources for solar panel manufacturers.

First Tellurium’s ESG Initiatives

Through its exploration and partnerships with Fenix Advanced Materials, Cheona Metals and IRMA, First Tellurium strives to generate a measurable, beneficial social or environmental impact alongside a financial return. The company conducts a diversified search for metals, working in alliance with indigenous peoples, NGOs, governments and leading metals buyers. First Tellurium believes this is the future of mineral exploration — generating revenue by exploring responsibly and leveraging diverse partnerships.

First Tellurium proudly adheres to, and supports, the principles and rights set out in the United Nations Declaration on the Rights of Indigenous Peoples and, in particular, the fundamental proposition of free, prior and informed consent.

 

Projects

Deer Horn Tellurium-Gold-Silver-Copper Project

Deer Horn is located on 51.33 square kilometers (km) in west-central British Columbia, 36 km south of the prolific Huckleberry copper-molybdenum mine and 135 km southwest of the community of Burns Lake. It is one of few significant tellurium discoveries outside Asia and includes a 2.4 km-long vein system of high-grade gold, silver and tellurium, as well as broader zones of bulk-tonnage gold, silver and tellurium mineralization. The company completed a positive Preliminary Economic Estimate and has begun permitting for a 10,000-tonne bulk sample program to advance the project toward mine feasibility. It is North America’s only silver-gold-tellurium property with an NI 43-101 compliant tellurium resource, and it hosts a number of other mineralized targets and zone containing critical metals such as copper, tungsten and zinc.

First Tellurium owns 50% of the property, with an option to acquire up to a 75% interest. The company has engaged Dias Geophysical of Saskatoon, Saskatchewan, to conduct induced polarization (IP) geophysics on the Deer Horn Project in summer 2023. The program is designed to help develop drill targets for a subsequent drilling program.

Klondike Gold-Tellurium Project

The Klondike property is located in Saguache County, Colorado, southwest of Buena Vista in the state’s historical mining district. The company reports it has engaged Burgex Mining Consultants of Sandy, Utah, to stake additional claims around the Klondike property. The claims have been filed with the Bureau of Land Management.

Klondike demonstrates exceptional tellurium grades. Tellurium, used in high-efficiency cadmium telluride (Cd-Te) solar panels, next-generation lithium-ion batteries and thermoelectric devices to change heat into energy, is an essential element for the world’s transition to green energy.

The Klondike property was a top tellurium prospect owned previously by First Solar Inc., one of the world’s largest solar panel producers. First Solar terminated its worldwide raw materials exploration program in 2012 and sold the property to Colorado Klondike LLC, which optioned the project to First Tellurium. Colorado Klondike, led by First Solar’s former Exploration Manager in North America, is managing the upcoming exploration program.

The Colorado Geological Survey (CGS), in partnership with the Colorado School of Mines, reported on First Solar’s exploration at Klondike in 2015, noting: “Surface sampling by First Solar, Inc. in 2006 found very high tellurium grades of up to 3.3% (33,000 ppm), along with locally high gold grades. Tellurium grades at Klondike were the highest encountered in the company’s nationwide exploration program.”

Market Outlook

First Tellurium in spring 2023 referenced recent forecasts by the International Energy Agency (IEA) pointing to rapid growth in solar photovoltaic (solar PV) deployment worldwide. According to the agency, solar PV installations will generate more power by 2027 than any other energy source, including coal, natural gas and hydro. To meet this demand, consumption of both silver and tellurium, key components of solar panels, is expected to surge in coming years.

Chen Lin, founder of Lin Asset Management, has written in his investment newsletter for clients that solar PV is now the largest industrial usage of silver. He said that in 2022 solar PV production used about 12% of total silver demand, or about 120 million ounces of silver. Lin expects this number to rise dramatically in the coming years, and that is likely to lead to silver supply deficits for decades to come.

Lin points out that solar power is now the cheapest source of energy in many parts of the world and that all forecasts point to dramatic expansion of solar PV in the coming two decades. Conservative estimates forecast 300 gigawatts of solar PV production by 2027, up from the current level of about 200 gigawatts.

Management Team

Tyrone Docherty is President, Director and CEO of First Tellurium Corp. He previously served as President and CEO of Quinto Mining Inc., taking over when it had a market cap of $4 million. With limited resources in a difficult market environment, he raised more than $30 million and advanced Quinto’s Quebec iron ore property to a viable project. Quinto later sold for $175 million, with Quinto management taking shares of the purchaser, Consolidated Thompson Iron Mines, amounting to approximately 20-21% of that company. Consolidated Thompson Iron Mines sold two years later for $4.9 billion, giving the former Quinto team an enterprise value of approximately $1 billion. From 2012 to 2018, Mr. Docherty was Director and Chairman of Mason Graphite Inc. He has worked in the financial and minerals markets for more than 30 years.

Tony Fogarassy, M.Sc. LL.M., is Chairman of First Tellurium Corp. He is a lawyer and a geologist. His extensive legal and technical expertise includes minerals, oil and gas, coal and renewable energy projects and environmental and aboriginal/indigenous law in North America, Africa and Asia. He graduated as gold medalist in geological sciences from the University of British Columbia and in law from the London School of Economics.

First Tellurium Corp. (OTCQB: FSTTF), closed Monday's trading session at $0.075, up 8.8534%, on 2,615 volume. The average volume for the last 3 months is 5,155 and the stock's 52-week low/high is $0.047785/$0.1765.

Recent News

Correlate Energy Corp. (OTCQB: CIPI)

The QualityStocks Daily Newsletter would like to spotlight Correlate Energy Corp. (OTCQB: CIPI).

Correlate Energy, a publicly traded distributed energy solutions company, is taking advantage of the expanding renewable energy landscape and is helping drive its adoption

Correlate has positioned itself as the go-to renewable energy solution, leveraging its three-pronged strategy that allows companies to make the move to highly efficient energy use and renewables, while minimizing transition costs

This comes as Amazon was recently ranked the largest corporate buyer of renewable energy in the world in 2023, spear-heading the movement toward renewable energy adoption and reliance

Correlate Energy (OTCQB: CIPI), a publicly traded company capitalizing on America's accelerating move toward cost effective renewable energy use, is looking to take advantage of the changing landscape and the growing reliance on renewable energy. As a company that understands this industry inside and out, Correlate is not only riding this wave but also helping drive it by identifying high-impact areas for improvement, addressing them, and delivering results. This has seen the company's products and services adopted by various legacy companies across the U.S., a testament to its overall value proposition.

Correlate Energy Corp. (OTCQB: CIPI) is a publicly-traded company strategically positioned to capitalize on America’s unstoppable trend toward decentralized energy generation.

The energy grid in the U.S. is insufficient for the booming clean energy trend, and current infrastructure is limiting green energy distribution. Constructing the needed infrastructure to address this demand imbalance will cost billions and be far too slow, positioning decentralized systems, like those on offer from Correlate, in a key position for heightened demand.

Correlate has identified several key economic drivers powering the decentralized energy trend, including:

  1. Real Cost Savings – Customer pays zero money down and gets an instant electrical price discount to current rates.
  2. Massive Project Investment Funding – The International Energy Agency estimates that over one billion dollars per day will be invested in solar energy in 2023.
  3. Consistent Long-Term Incentives – The Inflation Reduction Act is a game-changer, supercharging renewables with $1.2 trillion in tax credits for 10 years of market support.
  4. Robust Customer Demand – Wood Mackenzie expects the U.S. solar industry to nearly triple in size over the next five years.

Correlate’s team of multi-decade experts who have worked with renowned global brands are positioning the company to make the most of this opportunity while consolidating a fragmented industry. Collectively, the team has developed, financed and deployed over $2 billion in clean energy projects to date.

Three-Pronged Strategy

Correlate is leveraging a three-pronged strategy aimed at driving shareholder value:

  1. Sell – Correlate seeks to finance, develop and profitably sell localized clean energy solutions and microgrids to industrial, commercial and residential customers.
  2. Retain – Correlate plans to retain ownership of some of these energy systems and thereby realize ongoing, reliable cash flow.
  3. Acquire – Correlate seeks to acquire proven renewable energy companies in order to exponentially grow earnings per share for investors.

This strategy is enhanced by current investment trends. Clean energy earnings are being sought after by investors. In Q4 2022, the median EBITDA multiple for green energy companies was 12.3x, according to Finerva.

Market Outlook

Over the next decade and beyond, renewable energy growth is expected to come primarily via decentralized systems like those offered by Correlate.
The Inflation Reduction Act enacted in late August 2022 is likewise expected to drive growth for the company by providing new tax incentives that reduce costs for clients and/or elevate returns to investors.

Commercial buildings consume more than 35% of the generated electricity in the U.S. and are underperforming in energy efficiency at every level. These buildings waste energy, emit too much carbon and are too costly for owners and occupants, but retrofits are not happening at the rate or scale needed.

In today’s real estate market, portfolio property owners own most commercial buildings, yet most building efficiency work is focused on single buildings, thereby missing the distinct needs of this owner class which are very different from traditional owner-occupiers. The diverse nature of commercial buildings, combined with technology and performance uncertainty, make simple energy optimization initiatives – which could greatly reduce energy use and improve building value – financially unattractive, resulting in slow adoption rates. CIPI’s financial instruments and software breakdown this issue, known as the ‘split incentive’, unlocking the majority of the addressable market.

A key portion of Correlate’s strategy relates to consolidation of what has been a fragmented industry. By uncovering opportunities to improve efficiencies through strategic M&A activities, the company intends to enhance profitability throughout its operations.

Management Team

Todd Michaels is President and CEO of CIPI and founder of Correlate. He formerly served as Vice President for Innovation at SunEdison and Senior Director Distributed Solar at NRG Energy. He founded Correlate in 2015 and has 16 years of experience in the energy industry. He graduated from Indiana University with a B.S. in Computer Information Systems.

Channing Chen is CFO at CIPI and Correlate Inc. and brings over 16 years of experience in the solar industry as a developer, financier, and business unit leader. He has held executive management roles at Solar Power Partners (acquired by NRG Energy), where he was a founding employee, SunEdison, and NRG Energy (NYSE: NRG). Most recently, Mr. Chen was founder and Managing Partner at Breakaway Energy Partners LLC – a distributed energy financing and market-making platform. To date, Mr. Chen and his teams have raised over $1.5 billion in financing across residential, commercial, and utility scale solar and energy storage projects representing over 400 MWs. He holds a B.A. in Environmental Chemistry from the University of California at San Diego and an MBA from the University of Southern California. He is also an advisor and early-stage investor to several startup companies in the renewable energy space.

Dave Bailey is Chief Revenue Officer of Correlate Inc. With over 15 years of executive sales, supply chain management, and energy efficiency experience, he is responsible for ensuring the success of the National Commercial Sales Unit across multiple regional project teams. Mr. Bailey created and launched the Transformation Services team while at Wesco for its multibillion-dollar Distributed Energy Resource division, formerly Westinghouse. His focus was on IoT-enabled efficiency and plant floor automation-based services. Before that, he spent several years in Global Account Sales Management, with GE Supply as a Program Manager, and is a Commercial Leadership Program graduate. Mr. Bailey received his B.S. in Mechanical Engineering from the University of Kentucky.

Jed Freedlander is the company’s Chief Development Officer. He has a background in infrastructure development and investment and a strong legal, commercial and finance acumen. Mr. Freedlander has a proven track record in leading complex public-private partnership (P3) and energy transactions and is instrumental in driving Correlate’s strategic development initiatives.

Roger Baum is Executive VP Operations at Correlate. With over 20 years of experience at Core Construction, he brings to the company a wealth of knowledge and a strong track record in delivering successful commercial construction projects.

Jason Loyet is Director of Solar Energy for Correlate Inc. He is a cleantech executive with over 20 years of experience leading high growth solar energy and software start-ups. Mr. Loyet is a U.S. Department of Energy SunShot Catalyst award winner for his work building the Solar Site Design technology platform. Before joining the solar energy industry in 2005, he founded and sold two software companies in the streaming media (GlobalStreams) and newspaper publishing (MyCapture) industries. Mr. Loyet currently serves as a Member of the Board of Directors for the Tennessee Solar Energy Industry Association (TenneSEIA).

Correlate Energy Corp. (OTCQB: CIPI), closed Monday's trading session at $1.5, even for the day, on 335 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.1765/$.

Recent News

Software Effective Solutions Corp. (OTC: SFWJ)

The QualityStocks Daily Newsletter would like to spotlight Software Effective Solutions Corp. (OTC: SFWJ).

A coalition of military veterans' organizations is joining a growing number of entities encouraging the U.S. DEA to reschedule cannabis

The call to reschedule cannabis has gained momentum since the U.S. HHS sent a letter to the DEA supporting the change

Operating as MedCana, Software Effective Solutions has five divisions focused on pharmaceutical cannabis production

A growing number of organizations are calling for the rescheduling of cannabis from a Schedule I substance per the Controlled Substances Act ("CSA") to a Schedule III substance. The most recent group to voice is support of the change is a coalition of military veterans (https://cnw.fm/rbI0F). Companies operating in the cannabis space, including Software Effective Solutions (d/b/a MedCana) (OTC: SFWJ), are paying close attention to the mounting demand because the rescheduling would significantly change the landscape.

Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ) is a global infrastructure and holding company in the cannabis industry. MedCana currently has five companies focused on pharmaceutical cannabis production, as well a software company focused on managing processes for plant-to-patient operations. The recent acquisition of an irrigation and greenhouse technology company has rounded out MedCana’s portfolio of holdings.

MedCana’s focus is on developing clients and companies in Latin America, initially in Colombia, and partnerships with laboratories, research facilities and hospitals throughout the world. MedCana is building the technology, laboratories, growing facilities and scientific teams to provide premium pharmaceutical-grade cannabis extracts to the world.

MedCana’s goal is to be the world’s premier resource for pharmaceutical cannabis products. The company believes its advantage is its global view and reach. From initial cultivation to final product, MedCana aims to help partners produce pharmaceutical CBD and other extracts that will have no equal.

The company’s mission is to utilize its technology to partner with and develop companies that provide premium pharmaceutical-grade cannabis extracts with absolute integrity, sustainability and social responsibility. MedCana’s team of pharmaceutical scientists includes some of the most respected chemists in the world. They aim to ensure that the company’s customers and partners create premium cannabis extracts that meet the growing worldwide demand. MedCana’s software is designed to ensure traceability and quality from seed to finished product.

MedCana is headquartered in Austin, Texas, with offices in Colombia.

Production

MedCana announced in May 2023 the beginning of full-scale production of non-THC cannabis for export to Europe in response to high demand in that market. This expansion comes after the successful completion of full crop cycle testing and infrastructure development at production sites in Columbia.

The recent acquisition of the assets of Tokan Corp., a software company focused on creating an enterprise resource planning (ERP) platform for the cannabis industry, and Eko2O S.A.S., a greenhouse and irrigation engineering company, has positioned MedCana for explosive growth in the region.

As a MedCana subsidiary, Eko2O SA will increase the company’s revenue potential in Central and South America. The subsidiary specializes in the construction and distribution of greenhouses and sophisticated irrigation platforms. A positive outlook has resulted from the company’s expansion as it investigates new opportunities for greenhouse and irrigation system installations in Panama and Uruguay. These opportunities are expected to accelerate Eko2O’s development and strengthen its position as a top supplier of innovative agricultural solutions in cannabis and other sectors that are quickly moving to high technology agricultural production.

In addition, MedCana has started talks with the government in Argentina about possible incentives for beginning operations in that country as part of its ongoing worldwide development strategy. Support from the Argentinean government and the start of new operations there would greatly increase MedCana’s market share in Latin America and solidify the company’s position as the market leader in the cannabis industry.

Market Opportunity

According to a report by Grand View Research, a San Francisco-based market research and consulting company, the global cannabis extract market was valued at $3.5 billion in 2022 and is expected to expand at a CAGR of 20% from 2023 to 2030 to be worth more than $15 billion.

Growing demand for cannabis extracts, including oils and tinctures, and the increased legalization of marijuana for the treatment of different chronic ailments like arthritis, Alzheimer’s, anxiety and cancer are driving the expansion of the industry. The marijuana derivative industry is flourishing due to a greater understanding of its various medical benefits.

Management Team

Jose Gabriel Diaz is CEO of MedCana. He has successfully built, grown and sold multiple telecom companies. He was senior vice president of sales at IP Communications, a national high-speed data provider. He also founded Reallinx, a national data carrier later sold to GTT Communications. Additionally, he is currently president of the A.E.M. Business and Entrepreneurship Association in Austin, Texas.

Claudio Jiménez Cartagena, QF, Ph.D. is Chief Scientific Officer at MedCana. He joined MedCana after working with Sosteli Pharma as Technical Director and serving as a director consultant for the Corporation for Agricultural Industrial Development at the University of Antioquia in Colombia. Before that, he worked as the scientific director at the Institute of Food Science & Technology. He holds a bachelor’s degree in pharmaceutical chemistry, a master’s degree in basic biomedical sciences and a doctoral degree in Environmental Engineering from the University of Antioquia.

Julián Alberto Londoño Londoño, Ph.D., is Senior Vice President of Operations at MedCana. He previously served as general manager for the Corporation for Agricultural Industrial Development, and as Chief Scientific Officer at Sosteli Pharma in the Resource Management Department. He has developed multiple U.S. patents, and recently served as senior advisor to the Secretariat of Agriculture Development for the Government of Antioquia. He holds a doctorate in Chemical Sciences from the University of Antioquia.

Software Effective Solutions Corp. (OTC: SFWJ), closed Monday's trading session at $0.0558, off by 17.9412%, on 596 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.000001/$0.098.

Recent News

Diamond Lake Minerals Inc. (OTC: DLMI)

The QualityStocks Daily Newsletter would like to spotlight Diamond Lake Minerals Inc. (OTC: DLMI).

The hoopla surrounding crypto offerings' highs and lows has attracted scores of new investors in a sort of modern-day gold rush, but the unfamiliarity of the sector to many traditional investors has been off-putting

Utah-based Diamond Lake Minerals Inc. is redefining itself to attract digital asset-wary investors, by imbuing real world asset subsidiaries with security token offerings registered with the U.S. Securities and Exchange Commission ("SEC")

The company's board members are experienced professionals, and its CEO has been ranked among the world's Top 10 CEOs for three consecutive years recently by Adria Management, LLC in its World CEO Rankings Awards

The popularity of DLMI's approach has built a fan base, significantly increasing the company's share price within just a few months

Salt Lake City-based company Diamond Lake Minerals (OTC: DLMI) is becoming a rapidly evolving success in the digital asset sector as it redefines its purpose and sets a course to bring digital-wary investors into regulated security token offerings ("STOs") through a multi-strategy umbrella vision.

Diamond Lake Minerals Inc. (OTC: DLMI) is a multi-strategy operating company offering traditional investors an entry point to the future of digital securities. The company’s goal, through its established M&A roadmap, is to responsibly innovate and develop promising businesses that are likely to benefit from the ongoing shift toward digital assets. Through this approach, Diamond Lake Minerals provides traditional investors an opportunity to gain exposure to the emergence of regulated digital securities through a more familiar investment vehicle – the purchase of stock.

Founded in 1954 and headquartered in Salt Lake City, Diamond Lake Minerals is positioning itself as a leader in the digital asset and security token space. The company’s mission is to bring back to the public markets timeless business principles focused on healthy, sustainable growth and strong earnings with a goal of creating value for stakeholders in the modern digital world.

Diamond Lake Minerals believes the future of financial markets is set to be revolutionized by tokenization. Tokenization refers to the use of digital assets that can be traded via protocols with instantaneous settlement and reduced fees, eliminating the need for traditional clearing or settlement processes. Beyond efficiency, the emerging landscape emphasizes transparency, liquidity and security in asset management and investment.

With the backing of Esposito Intellectual Enterprises and its 20+ years of experience, Diamond Lake Minerals has access to the expertise of 110+ companies and 200+ joint ventures, along with knowledge spanning 25+ industries. The company is creating a vertically integrated ecosystem that encompasses various high-growth sectors. This integration aims to maximize operational efficiencies and profitability across all business units.

Products & Services Portfolio

Diamond Lake Minerals, guided by its strategic partnerships and future roadmap, envisions a diverse portfolio across multiple industries, as shown in the overview below. The company is poised to redefine the conglomerate model for the 21st century, with a focus on vertical integration, digital securities and sustainable growth.

Its target market segments include:

  • Fashion: DLMI seeks stakes in brands blending timeless aesthetics with tech influences.
  • Beauty: DLMI eyes partnerships with innovators elevating beauty through sustainable practices.
  • Real Estate: DLMI aims for interests in ventures modernizing property transactions via blockchain.
  • Hospitality: DLMI’s vision includes associations with enterprises enhancing guest experiences via tech integration.
  • Liquor: DLMI aspires to collaborate with unique distillers merging tradition and innovation.
  • IoT: DLMI intends to invest in solutions seamlessly connecting the digital and physical worlds.
  • Wireless: DLMI envisions stakes in wireless tech optimizing global communication.
  • Technology: DLMI plans to back pioneers driving the next tech revolution.
  • Maritime: DLMI seeks partnerships in maritime solutions emphasizing green initiatives.
  • Aviation: DLMI’s strategy includes holdings in aviation innovators focusing on efficiency.
  • Aerospace: DLMI aims to support ventures pushing boundaries in space exploration.
  • Education: DLMI collaborates with platforms revolutionizing learning through tech.
  • Charity: DLMI eyes alliances with charitable entities leveraging transparency via blockchain.
  • Healthcare: DLMI foresees investments in healthcare tech personalizing patient care.
  • TV: DLMI intends stakes in TV platforms innovating content delivery.
  • Film: DLMI aspires to support filmmakers merging storytelling with immersive tech.
  • Music: DLMI plans interests in music ventures amplifying artists through digital platforms.
  • Entertainment: DLMI targets stakes in platforms redefining entertainment paradigms.
  • IP: DLMI envisions collaborations safeguarding intellectual properties via tech solutions.
  • Data Management: DLMI seeks ventures optimizing data utilization and insights.
  • Data Storage: DLMI’s roadmap includes alliances with secure data storage solutions.
  • Streaming: DLMI intends to back streaming platforms prioritizing user experience.
  • Real World Assets: DLMI eyes investments translating tangible assets into digital value.
  • Gold & Silver: DLMI aims for stakes in platforms digitizing precious metal trading.
  • Sports: DLMI envisions collaborations enhancing sports experiences via tech integration.
  • Sports Technology: DLMI seeks ventures revolutionizing athlete performance and fan engagement.
  • Water: DLMI plans to back solutions ensuring water sustainability and accessibility.
  • Water Treatment: DLMI targets investments in eco-friendly water purification technologies.
  • Animation: DLMI eyes stakes in animation houses blending art with cutting-edge tech.
  • Studio Production: DLMI’s vision includes support for studios transforming content creation.
  • Consumer Products: DLMI seeks partnerships with brands prioritizing consumer-centric innovations.
  • Collectables: DLMI envisions collaborations with platforms digitizing unique collectibles.
  • Digital Assets: DLMI aims to invest in ventures maximizing the potential of digital ownership.
  • Web3: DLMI aspires to back pioneers ushering in the decentralized web era.
  • Identity Management: DLMI eyes solutions prioritizing user identity security in the digital space.
  • Media & Journalists: DLMI seeks alliances promoting unbiased reporting and content democratization.
  • Metaverse: DLMI envisions stakes in ventures crafting immersive virtual universes.
  • Space Economy: DLMI targets investments in ventures monetizing space exploration.
  • Modular Homes: DLMI plans interests in solutions revolutionizing home construction.
  • Financial Technology: DLMI seeks partnerships modernizing financial transactions.
  • Gaming: DLMI aims to back game developers enhancing user immersion.
  • Travel: DLMI eyes collaborations transforming travel experiences through tech.
  • Health & Wellness: DLMI’s strategy includes investments in holistic health tech solutions.
  • Augmented Reality: DLMI envisions stakes in AR platforms blurring reality and digital.
  • AI: DLMI seeks to support AI innovations humanizing tech interactions.
  • Esports: DLMI targets investments in platforms amplifying esports experiences.
  • Construction: DLMI plans to back ventures modernizing construction practices.
  • Virtual Reality: DLMI intends stakes in VR platforms offering alternate realities.
  • Retail Tech: DLMI envisions collaborations digitizing retail experiences.
  • Biotechnology: DLMI seeks ventures pushing boundaries in biotech innovations.

Market Opportunity

According to Diamond Lake Minerals’ business plan executive summary, the market for digital securities is projected to grow from $10 billion in 2022 to $1 trillion by 2028, a CAGR of 45% for the forecast period.

The global blockchain market value is expected to grow from an estimated $3 billion in 2020 to $39.7 billion by 2025, marking a CAGR of 67.3% for the period. Valued at $2.28 billion in 2021, the Security Token Offerings market is projected to grow at a CAGR of 19%. This growth is expected to be driven by the rising adoption of tokenization and the increasing prominence of STOs, especially in North America.

In addition, the global investment management market is projected to grow from a value of $100 trillion in 2020 to $178 trillion by 2025, recording a CAGR of 7.2% over the period.

Management Team

Brian J. Esposito is CEO of Diamond Lake Minerals. As founder and CEO of Esposito Intellectual Enterprises LLC, he brings over 20 years of diverse experience in sectors like manufacturing, technology, music and real estate, and is known for his global executive networking and balance sheet optimization skills.

Michael Reynolds is President and Director of Diamond Lake Minerals. With 35 years in private finance and M&A, he has been instrumental in growing companies like Herbalife through reverse acquisition, as well as elevating JB Oxford to $120 million in revenue. His expertise in operational management and business development ensures professional solutions for clients’ business interests.

Jon Karas is DLMI’s senior transaction and investment executive. As the CEO and co-founder of Akon Legacy Ventures, he structured, negotiated and closed numerous transactions focused on innovation and social impact in smart cities, blockchain, agriculture, mining and technology. He co-founded and led multiple companies in media and entertainment and was the driving force behind the development, financing and production of a broad range of film and television content.

Advisory Board

Anthony Scaramucci, Founder and Managing Partner of SkyBridge Capital and Chairman of SALT, brings to Diamond Lake Minerals unparalleled expertise in finance, technology and business strategy. He is expected to be instrumental in shaping DLMI’s strategic direction as the company continues to redefine the future of traditional and digital securities.

Larry Namer, Founder of E! Entertainment TV and President of Metan Global, boasts a remarkable career spanning more than half a century. He is an esteemed veteran of the entertainment industry, renowned for his influential contributions to cable television, live events, music and new media. He also leads LJN Media, a consulting firm known for its cross-industry expertise in technology, business and finance.

Andrew Fromm is a seasoned CEO and consultant with a focus on music publishing. He is known for his expertise in asset sales, songwriting and artist development. His extensive network extends beyond the music industry, showcasing his versatility and authority in the field.

Brandon Fugal is the Chairman of Colliers International in Utah and a former EY Entrepreneur of the Year. He has co-founded multiple ventures, including Coldwell Banker Commercial Advisors, Cypher, Axcend and Texas Growth Fund, and he is a recognized authority in real estate and entrepreneurship.

Michael Malik Sr. is a Detroit-based entrepreneur with a $750 million net worth, known for his pivotal role in legalizing gambling and developing major casino projects across the U.S., including Detroit’s MotorCity Casino and various Native American gaming ventures. He brings to Diamond Lake Minerals a wealth of experience and a proven track record in the gaming, sporting and entertainment industries spanning over five decades.

Raul Leal is an experienced CEO in the hospitality sector, known for his visionary leadership at SH Hotels & Resorts and former role at Virgin Hotels, where he secured over $500 million in funding and revolutionized guest experiences.

Agnes Budzyn, an accomplished entrepreneur and CEO of Bluedge Ventures, brings to the company a rich history in traditional finance and blockchain technology, serving on various global boards and committees. She has been recognized by the World Economic Forum and numerous institutions for her expertise and contributions to bridging legacy finance with emerging digital asset infrastructure.

Diamond Lake Minerals Inc. (OTC: DLMI), closed Monday's trading session at $5.55, off by 3.4783%, on 1,776 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.35/$5.90.

Recent News

Lexaria Bioscience Corp. (NASDAQ: LEXX)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (NASDAQ: LEXX).

Lexaria, a global innovator in drug delivery platforms, has announced its GLP-1 research plans for the 2024 calendar year

The company will kick off its chronic dosing animal study in March/April, followed by the human pilot study #2, kicking off at around the same time

The third human pilot study will start in May/June followed by a chronic dosing human study that will involve 70-90 pre-diabetic and type-2 diabetic human patients

These studies will evaluate DehydraTECH for the improved delivery of GLP-1 drugs, designed to support prospective commercial partnering with global pharmaceutical companies

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, has announced its research plans for the evaluation of its patented DehydraTECH(TM) technology for the improved delivery of GLP-1 drugs designed to support prospective commercial partnering with global pharmaceutical companies.. This builds on the success achieved from a recent human pilot study, which yielded impressive results, demonstrating superior pharmacokinetic ("PK") oral delivery performance of the DehydraTECH-enhanced GLP-1 drug, semaglutide, which is currently available commercially as Rybelsus(R) (https://cnw.fm/Z5F9w).

Lexaria Bioscience Corp. (NASDAQ: LEXX) is a global innovator in drug delivery platforms. The company’s patented technology, DehydraTECH™, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting healthier oral ingestion methods and increasing the effectiveness of fat-soluble active molecules. DehydraTECH promotes fast-acting, less expensive and more effective oral drug delivery and has been thoroughly evaluated through in vivo, in vitro and human clinical testing.

DehydraTECH is covered by 21 issued and more than 50 pending patents in over 40 countries around the world. Lexaria’s first patent was issued by the U.S. Patent and Trademark Office in October 2016 (US 9,474,725 B1), providing 20 years of patent protection expiring June 2034. Multiple patents have been awarded since then and are expected in the future.

Lexaria has also collaborated with the National Research Council (NRC), the Canadian government’s premier research and technology organization. The company has been granted patent protection for specific delivery of nicotine, vitamins, NSAIDs, antiviral drugs, cannabinoids and more.

Lexaria began developing DehydraTECH in 2014 and has since continued to strengthen and broaden the technology. The company has no plans to create or sell Lexaria-branded products containing controlled substances. Instead, Lexaria licenses its technology to other companies around the world to offer consumers the best possible performance across an array of ingestible product formats.

The company’s technology is best thought of as an additional layer that providers of consumer supplements, prescription and non-prescription drugs, nicotine and CBD products can utilize to improve the effectiveness of their own existing or planned new offerings. Lexaria has licensed DehydraTECH to multiple companies, including a world-leading tobacco producer for the research and development of smokeless, oral-based nicotine products, and for use in industries that produce cannabinoid beverages, edibles and oral products.

DehydraTECH is suitable for use with a wide range of product formats including pharmaceuticals, nutraceuticals, consumer packaged goods and over-the-counter capsules, pills, tablets and oral suspensions.

DehydraTECH Technology

Lexaria’s DehydraTECH is designed specifically for formulating and delivering lipophilic (fat-soluble) drugs and active ingredients. DehydraTECH increases their effectiveness and improves the way active pharmaceutical ingredients enter the bloodstream. The major benefits to a subject ingesting a DehydraTECH-enabled drug or consumer product can be summarized by the following:

  • Speeds up delivery – the effects of the product are felt by the subject in just minutes.
  • Increases bioavailability – the technology is much more effective at delivering a drug or product into the bloodstream.
  • Increases brain absorption – animal testing suggests significant improvement in the quantity of drug delivered across the blood-brain barrier.
  • Improves drug potency – more of the ingested product is made available to the body, so lower doses are required to achieve the desired effect.
  • Reduces drug administration cost – lower doses mean lower overall drug costs.
  • Masks unwanted taste – the technology eliminates or reduces the need for sweeteners.

Lexaria has demonstrated in animal studies a propensity for DehydraTECH technology to elevate the quantity of drug delivered across the blood-brain barrier by as much as 1,900 percent, initiating additional new patent applications and opening possibilities for improved drug delivery.

Since 2016, DehydraTECH has repeatedly demonstrated, with cannabinoids and nicotine, the ability to increase bio-absorption by up to five to 10 times, reduce time of onset from one to two hours to just minutes, and mask unwanted tastes. The technology is to be further evaluated for additional orally administered bioactive molecules, including antivirals, cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs) and nicotine.

Market Outlook

Lexaria’s ongoing research and development efforts are mainly focused on development of product candidates across several key segments:

  • Oral Cannabinoids – a market estimated to be worth $18.4 billion in 2021 and expected to reach $46.2 billion by 2025.
  • Antivirals – an estimated $52.1 billion market in 2021 that’s expected to grow to $66.7 billion by 2025.
  • Oral Mucosal Nicotine – smokeless tobacco products, a $13.6 billion market in 2018, is forecast to grow at 7.2 percent annually through 2025.
  • Human Hormones – estrogen and testosterone replacement therapies represented a $21.9 billion market in 2019, with a forecast CAGR of 7.7 percent through 2027.
  • Ibuprofen and Naproxen – NSAID sales totaled $15.6 billion globally in 2019 and are projected to reach $24.4 billion by 2027.
  • Vitamin D3 – the global market size was $1.1 billion in 2021, growing at 7 percent per year and expected to reach $1.7 billion in 2026.

Management Team

Chris Bunka is Chairman and CEO of Lexaria Bioscience Corp. He is a serial entrepreneur who has been involved in several private and public companies since the late 1980s. He has extensive experience in the capital markets, corporate governance, mergers and acquisitions, as well as corporate finance. He is named as an inventor on multiple patent innovations.

John Docherty, M.Sc., is the President of Lexaria. He is a pharmacologist and toxicologist, and a specialist in the development of drug delivery technologies. He is the former president and COO of Helix BioPharma Corp. (TSX: HBP). He is named as an inventor on multiple issued and pending patents.

Greg Downey is Lexaria’s CFO. He has more than 35 years of diverse financial experience in the mining, oil and gas, manufacturing, and construction industries, and in the public sector. He served for eight years as CFO for several public companies and has provided business advisory and financial accounting services to many large organizations.

Gregg Smith is a strategic advisor to Lexaria. He is a founder and private investor with Evolution VC Partners. He is a member of the Sand Hill Angels and held previous investment banking roles with Cowen and Company and Bank of America Merrill Lynch.

Dr. Philip Ainslie serves as a scientific and medical advisor to Lexaria. He is co-director for the Centre for Heart, Lung and Vascular Health, Canada. He is also Research Chair in Cerebrovascular Physiology and Professor at the School of Health and Exercise Sciences, Faculty of Health and Social Development at the University of British Columbia.

Lexaria Bioscience Corp. (LEXX), closed Monday's trading session at $1.5, up 5.6338%, on 41,863 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.6488/$3.5953.

Recent News

SOBRsafe Inc. (NASDAQ: SOBR)

The QualityStocks Daily Newsletter would like to spotlightFathom SOBRsafe Inc. (NASDAQ: SOBR).

SOBRsafe's alcohol detection technology can improve behavioral outcomes and help save lives

Navix Health, a leading provider of innovative behavioral healthcare support technologies, has chosen SOBRsafe as its exclusive alcohol data partner, integrating SOBRsafe's transdermal detection solutions into Navix Hub(TM)

SOBRsafe's products include SOBRsafe(TM), SOBRcheck(TM), and SOBRsure(TM)

SOBRsafe (NASDAQ: SOBR), a provider of advanced transdermal alcohol detection technology, recently announced that Navix Health, a leading provider of behavioral healthcare support technologies, has chosen SOBRsafe as its exclusive alcohol data partner, integrating the company's transdermal detection solutions into Navix Hub(TM). With the integration of SOBRsafe into Navix Hub, customers can augment current operations with touch-based alcohol monitoring, with the results flowing directly into their client records platform. The collaboration marks a significant milestone in advancing digital health and enhancing patient-centric care (https://ibn.fm/38npo).

SOBRsafe Inc. (NASDAQ: SOBR) is a provider of a game-changing transdermal (touch-based) alcohol detection technology that can improve workplace safety and provides advanced screening and monitoring solutions for the behavioral health industry.

Alcohol misuse is the fourth leading cause of preventable death in the U.S., and the seventh worldwide. Nearly half of all industrial accidents with injuries are alcohol-related, and 1-in-10 U.S. commercial drivers tests positive for alcohol – the highest rate in the world. Despite these statistics, prevention and monitoring solutions have not kept pace with this epidemic. Legacy detection technologies are invasive and inefficient, unhygienic and unconnected. SOBRsafe believes there is a better way.

The company has developed a patent-pending alcohol detection device called SOBRcheck™ for use in detecting alcohol in humans, with just the touch of a finger. SOBRsafe’s next-generation transdermal technology detects and instantaneously reports the presence of alcohol as emitted through a user’s skin. No breath, blood or urine sample is required. SOBRsafe believes its technology is a superior, hygienic alternative to traditional breathalyzers for frontline, preventative applications.

With a powerful backend data platform, SOBRsafe provides humane, passive and connected alcohol detection for the behavioral health, transportation, oil and gas, judicial and consumer markets.

A preventative solution in historically reactive industries, SOBRsafe technology is being deployed for commercial fleets, workplaces, alcohol rehabilitation, probation management and teen drivers. This monitoring technology helps prevent intoxicated workers from taking the factory floor or drivers from receiving the keys to a truck, bus or family car. An offender is immediately flagged, and an administrator is empowered to take the appropriate corrective actions.

SOBRsafe technology is commercially available for access control (SOBRcheck), wearable use (SOBRsure™) and licensing or white labeling.

The company is headquartered in the Denver (CO) Technology Center.

Products

The SOBRsafe technology is integrated within the company’s robust and scalable data platform, producing statistical and measurable user and business data.

SOBRsafe™

With a mission is to save lives, increase productivity, create significant economic benefits and positively impact behavior, SOBRsafe developed the scalable, patent-pending SOBRsafe™ platform for non-invasive alcohol detection, real-time reporting and historical data aggregation.

SOBRsafe is a solution that has broad applications in behavioral health, fleet and facility safety, youth drivers and judicial markets.

SOBRcheck™

SOBRcheck is the company’s stationary identification and alcohol monitoring product, providing a quick, specific-point-in-time test for the presence of alcohol. In hygienic, real-time fashion, SOBRcheck verifies user identity and determines the absence or presence of alcohol.

SOBRcheck provides an administrator immediate results – delivered securely – to aid in the efficient management of an existing substance abuse policy.

SOBRsure™

SOBRsure is the company’s transdermal, alcohol-detecting wearable. SOBRsure provides continuous, mobile alcohol monitoring. The band’s advanced alcohol safety technology discreetly detects and instantaneously reports the presence of alcohol in the body. Additionally, SOBRsure provides app-based alcohol detection alerts, pinpoint location tracking and band-removal notifications.

The SOBRcheck and SOBRsure revenue models consist of two components: (1) a hardware device purchase and (2) a recurring monthly SaaS subscription fee.

Design, manufacturing, quality testing and distribution for all SOBRsafe devices takes place in the U.S.

 

Market Opportunity

A report from Data Bridge Market Research, an international market research and consulting firm, estimated the global alcohol sensor market at $2.3 billion in 2022. The market is forecast to reach a value of $6.3 billion by 2030, recording a CAGR of 13.7% over the forecast period.

Market growth drivers, as cited by the report, include rising alcohol consumption rates, more stringent laws pertaining to alcohol consumption and new, more effective technologies that facilitate detection and enforcement.

Greater awareness of alcohol consumption as a potential threat to public and workplace safety has led to increased emphasis on preventing operation of motor vehicles and machinery by those under the influence of alcohol and promoting responsible alcohol consumption, as the report details.

Management Team

David Gandini is Chairman and CEO of SOBRsafe. He most recently served as president of IPS Denver, a bank card personalization company. Prior to that, Dave was the COO at First World Communications, a U.S. internet and data center provider, and participated in its successful IPO. He previously founded Pace Network Services and facilitated a successful exit to ICG Communications. Dave also co-founded Detroit-based Digital Signal in the fiber optic long haul market sector, where he executed a successful exit to SP Telecom.

Chris Whitaker, CPA, is CFO of SOBRsafe. Previously, Chris had served as the Company’s Vice President of Finance and Accounting. He has held various executive finance positions with large public multi-national corporations and small entrepreneurial companies throughout a progressive 30-year career that began with KPMG. Chris was formerly President – Americas and Vice President of Finance and Administration for public, multinational corporation Elixinol. He also served as the Managing Director of AEGIS Financial Consulting, leading a team of consultants in providing fractional CFO and financial consulting services to a wide variety of businesses in the public and private sectors.

Scott Bennett is EVP, Business Operations at SOBRsafe. He has more than 20 years of experience as a senior executive in technology-driven enterprises. Prior to joining SOBRsafe, he co-founded cybersecurity firm GBprotect and served as its COO until its successful sale to Nuspire. He previously served as Chief Technical Officer/Chief Information Security Officer of fintech businesses Catalyst Card Company and Integrated Printing Solutions.

SOBRsafe Inc. (NASDAQ: SOBR), closed Monday's trading session at $0.47, up 11.9314%, on 231,752 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.2004/$3.16.

Recent News

Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF)

The QualityStocks Daily Newsletter would like to spotlight Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF).

Eloro Resources (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM), a leading exploration and mine development company, is reporting that an expanded induced polarization/resistivity ("IP/Res") survey now covers most of the Iska Iska Project, which is located in southwestern Bolivia. According to the announcement, the survey includes east-west lines that have been completed every 200 meters across as well as southeast of the Santa Barbara mineral resource; the lines use a deep-penetrating array of 50 meters and offset 100 meters dipoles. The survey is designed to reach a depth of investigation approaching 400 meters. The company is reporting that the new array and lower surface elevations make it possible to image mineralization at elevations below 3,600 meters in an extended area beyond the open southeastern side of the pit. The survey indicates that chargeability highs across the volume already drilled for the Santa Barbara MRE coincide with peaks in the grade of the polymetallic Ag-Zn-Pb mineralization expressed as silver equivalent.

The report also noted that the chargeability anomaly southeast of the pit is extremely strong, making the area a prime target potentially outlining additional higher-grade polymetallic mineralization. "We have had great success with our borehole IP/Res program correlating mineralization between the drillholes, but the surface IP/Res provides a three-dimensional view well beyond where we have drill hole coverage," said Eloro Resources executive vice president Dr. Bill Pearson in the press release. "The new chargeability anomaly, extending southeastward from the open pit that defines the MRE, adds at least an additional 600 meters of potential strike length to the major mineralized structural corridor that is up to 800 meters wide for an overall strike length of at least two kilometers. This new target area has not been drilled. In addition, the chargeability anomaly southeast of the pit is very strong, suggesting that it is a prime target for outlining additional higher-grade polymetallic mineralization."

To view the full press release, visit https://ibn.fm/DIToO

Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) is a publicly traded exploration and mine development company with a portfolio of gold and base-metal properties in Bolivia, Peru and Quebec.

The company has an option to acquire a 99% interest in the highly prospective Iska Iska Property, classified as a silver-tin polymetallic epithermal-porphyry complex, a significant mineral deposit type in the Potosi Department of southern Bolivia. Iska Iska is a road-accessible, royalty-free property.

Eloro also owns an 82% interest in the La Victoria Gold/Silver Project, located in the North-Central Mineral Belt of Peru, some 50 kilometers south of Barrick’s Lagunas Norte Gold Mine and Pan American Silver’s La Arena Gold Mine. La Victoria consists of eight mining concessions and eight mining claims encompassing approximately 89 square kilometers. La Victoria has good infrastructure, with access to road, water and electricity, and is located at an altitude that ranges from 3,150 meters to 4,400 meters above sea level.

The company has a strong management and technical team working diligently to uncover the value of both Iska Iska and La Victoria. Eloro is based in Toronto, Canada.

Projects

Iska Iska – Potosi, Bolivia

Iska Iska is associated with a Miocene possibly collapsed/resurgent caldera, emplaced on Ordovician age rocks with major breccia pipes, dacitic domes and hydrothermal breccias. The property is wholly controlled by the title holder, Empresa Minera Villegas S.R.L. It is located 48 kilometers north of Tupiza city, in the Sud Chichas Province of the Department of Potosi. This is an important mineral deposit type in the prolific South Mineral Belt of Bolivia. Eloro commissioned a NI 43-101 Technical Report on Iska Iska, which was completed by Micon International Limited and is available on Eloro’s website and under its filings on SEDAR.

A fully financed drill program is currently underway on the property, situated near world-class deposits including Silver Sand, San Bartolomé, Pulacayo, San Cristobal, San Vicente, Chorolque, Tasna, Choroma and Siete Suyos. Iska Iska is in the southwest part of the Eastern Cordillera, which hosts a number of major polymetallic mines and mineral deposits. Drilling and continuous channel sampling results have demonstrated some very high metal values, especially silver and tin, within an immense system, where mineralization has been encountered in every drill hole to date. The company believes there is excellent potential for world-class bulk mineable deposits.

La Victoria – Ancash, Peru

The La Victoria project, targeting gold and silver production, is situated near world-class, low-cost gold producers Pan American Silver and Barrick Gold Corporation. Located in Ancash Department, La Victoria sits on the western slopes of the Peruvian Andes. The property is located 12 hours from Lima, with a travel distance of 600 kilometers. The nearest road accessible population centers from La Victoria are Huandoval, Pallasca and Cabana. The project includes four principal mineralized zones in Peru’s prolific North-Central Mineral Belt – San Markito, Victoria, Victoria South and Ccori Orcco – with excellent potential for gold discovery. Operations at La Victoria are planned to proceed with a 2,000-meter diamond drilling program to test targets to outline potential resources at San Markito. Trenching and sampling confirmed high silver values and veins at San Markito in 2020.

Market Outlook

According to industry association The Silver Institute, the outlook for silver demand is exceptionally promising, with global demand forecast to rise to a record high of 1.112 billion ounces in 2022. The increase will be driven by record silver industrial fabrication, which is forecast to improve by 5%, as silver’s use expands primarily in solar energy and electric vehicle (EV) manufacturing. The institute states that government commitments to carbon neutrality have resulted in a rapid expansion of green energy projects, driving record photovoltaic panel installations which are expected to lift silver demand in this segment to an all-time high in 2022.

Rising demand in the electronics industry is also boosting the demand for tin, which is primarily used in solder. The electronics and electrical industries use solders containing 40-70% tin, which provide strong and reliable joints under a variety of environmental conditions. At present, the majority of the assemblers are using patented tin-and-copper-based solders. Mordor Intelligence estimated tin demand at 387 kilotons in 2021 and forecasts demand growth of 2.5% annually through 2027. Over the medium term, surging demand from the EV market and increasing applications in the electrical and electronics industry is expected to drive the market.

Management Team

Thomas G. Larsen is CEO of Eloro. He has more than 40 years of experience in the investment industry, specializing in corporate finance and management of junior resource companies, raising in excess of C$200 million. He previously held the position of President and Chief Executive Officer of Champion Iron Limited. Prior to that, he was President and Chief Executive Officer of Champion Iron Mines Limited.

Dr. Bill Pearson is Executive VP of Exploration for Eloro. He has more than 40 years of direct experience in the exploration and production of minerals worldwide. He played an integral role in the acquisitions of Desert Sun Mining Corp. by Yamana Gold in 2006 and Central Sun Mining by B2 Gold in 2009. He was formerly VP Exploration at Desert Sun Mining and Senior VP at Central Sun Mining.

Miles Nagamatsu, CPA, is CFO at Eloro. He has over 30 years of experience in accounting, management, lending, restructurings and turnarounds. Since 1993, he has acted as a CFO of public and private companies primarily in the mineral exploration and investment management sectors. He holds a Bachelor of Commerce degree from McMaster University.

Osvaldo Arce Burgoa is General Manager at Eloro. He is a geological and mineral processing engineer with 26 years of experience in Bolivia. He is a former President of the Bolivian Geological Society, Main Technical Advisor of the National Mining Corporation (COMIBOL) and has served as exploration manager and chief geologist at various mining and exploration companies. He has authored two books on Bolivian geology and holds a doctorate in mining engineering from Tohoku University in Sendai, Japan.

Eloro Resources Ltd. (OTCQX: ELRRF), closed Monday's trading session at $1.394, up 2.9542%, on 43,303 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $1.026/$3.135.

Recent News

Longeveron Inc. (NASDAQ: LGVN)

The QualityStocks Daily Newsletter would like to spotlight Longeveron Inc. (NASDAQ: LGVN) .

Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, has received notice from the United States Patent and Trademark Office ("USPTO") of patent allowance for Medicinal Signaling Cells ("MSCs"). The patent covers the technology behind LGVN's lead investigational product Lomecel-B(TM) and will impact patients with Aging-related Frailty receiving vaccines for conditions such as COVID-19 and the flu. Lomecel-B is a living-cell product made from MSCs that are essential to the body's endogenous biological repair mechanism and that have been shown to perform complex functions in the body, including the formation of new tissue. The patent covers the impact of Lomecel-B on favorable modulation of the immune system, which is a foundational mechanism of action of the product. Longeveron is currently conducting trials in Aging-Related Frailty and Alzheimer's disease as well a phase 2 trial for Hypoplastic Left Heart Syndrome ("HLHS"), a rare and often fatal cardiac condition in newborn infants. "These newly allowed claims extend our patent estate to include the use of Lomecel-B in conjunction with or after patients receive vaccines to enhance vaccine immune response," said Longeveron  cofounder, chief scientific officer and chair Joshua M. Hare, MD, FACC, FAHA, in the press release. "We believe this use for Lomecel-B and the broader potential it holds for patients in our current Aging-Related Frailty and Alzheimer's disease trials reflects the broader potential of Lomecel-B."

To view the full press release, visit https://ibn.fm/pIscy

Longeveron Inc. (NASDAQ: LGVN) is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. The Company’s research and therapies are aimed at improving the outcome of infants born with a life-threatening heart condition, as well as improving the healthspan for the aging population – the number of years a person is expected to live in relatively good health, free of chronic disease and disabilities of aging, with function and ability to perform activities of daily living.

Longeveron is involved in clinical trials in the following indications: Hypoplastic left heart syndrome (HLHS), Alzheimer’s disease, and Aging-related Frailty.

The Company’s philosophy revolves around the idea that regenerative medicine may hold the potential to improve certain rare medical conditions and contribute to healthy aging. While there has been a remarkable rise in life expectancy over the last century due to medical and public health advancements, this increase in longevity has not been paralleled by the number of years a person is expected to live in relatively good health, free of chronic disease and disabilities of aging.

Longeveron’s lead investigational product is Lomecel-B™, an allogeneic Medicinal Signaling Cell therapy product isolated from the bone marrow of young, healthy adult donors. As humans age, they experience a decrease in immune system function, a decline in blood vessel functioning, chronic inflammation, and other issues. Clinical data has suggested that Lomecel-B™ may address these conditions through multiple mechanisms of action (MOA) that simultaneously target key aging-related processes.

The Company is headquartered in Miami, Florida.

Lomecel-B™

Lomecel-B™ is being evaluated in multiple clinical trials for aging-related chronic diseases and other life-threatening conditions under U.S. FDA-approved Investigational New Drug applications. Lomecel-B™ has multiple potential mechanisms of action encompassing pro-vascular, pro-regenerative, anti-inflammatory, and tissue repair and healing effects with broad potential applications across a spectrum of disease areas.

The drug is made from special living cells called Medicinal Signaling Cells (MSCs) that are isolated from fresh bone marrow tissue that has been donated by adult donors aged 18 to 45. Once the MSCs have been isolated from the fresh bone marrow through a careful selection process, the cells are culture-expanded (allowed to replicate under controlled laboratory conditions) into the billions using specialized techniques and processes. After a specific number of expansion cycles, called “passages,” the cells are harvested, separated into specific doses (e.g., 50 million cells), and cryopreserved until future use.

These cells have been shown to have characteristics that allow them to be transplanted from a donor to host without triggering a harmful immune response in the recipient, and they can be administered on an outpatient basis in as little as 40 minutes after thawing. Because of these characteristics, Lomecel-B™ is considered an “off-the-shelf” product.

In some trials, such as for Alzheimer’s disease and Aging-related Frailty, Lomecel-B™ is administered via peripheral intravenous infusion, while, in the Company’s HLHS trial, Lomecel-B™ is administered via direct injection into the heart tissue.

Market Opportunity

Longeveron estimates the potential market size for Lomecel-B™ in the treatment of HLHS to be up to $1 billion annually, globally.

U.S. patients suffering from Aging-related Frailty are estimated using U.S. Census Bureau statistics to be approximately 8.1 million. That population potentially represents a market for Lomecel-B™ of between $4 billion and $8 billion globally per year, according to Company estimates.

Additionally, the Alzheimer’s Association puts the number of Americans with that disease at 5.1 million, highlighting another potentially addressable market for Lomecel-B™, that’s worth $5 billion to $10 billion annually.

Management Team

Wa’el Hashad is CEO of Longeveron. He has more than 35 years of experience in the pharmaceutical and biotech industries. He has launched several successful brands in the U.S. and worldwide markets. Prior to joining Longeveron, he was president and CEO of Avanir Pharmaceuticals. Before Avanir, he was the chief commercial officer of Seres Therapeutics. He also has held senior leadership positions at Amgen, Boehringer Ingelheim, and Eli Lilly and Company. He holds a bachelor’s degree in pharmacy from Cairo University and an MBA from the University of Akron.

Joshua M. Hare, M.D., FACC, FAHA, is Co-Founder, Chief Science Officer and Chairman of Longeveron. He is a double board-certified cardiologist and is the founding director of the Interdisciplinary Stem Cell Institute at the University of Miami’s Miller School of Medicine. He is a recipient of the Paul Beeson Physician Faculty Scholar in Aging Research Award and is an elected member of the American Association of Physicians and The American Society for Clinical Investigation. He is also an elected Fellow of the American Heart Association. He received a bachelor’s degree from the University of Pennsylvania and his M.D. from The Johns Hopkins University School of Medicine.

Lisa Locklear is CFO at Longeveron. She previously served as the senior vice president and CFO for Avanir Pharmaceuticals. Prior to Avanir, she held senior financial roles at GSN Games, CoreLogic, Ingram Micro, the Walt Disney Company, and Price Waterhouse, with assignments in Paris and London. She holds a bachelor’s degree in plant science from the University of California, Davis, and an MBA from the University of California, Irvine. She is a licensed CPA (inactive) and is a member of the American Institute of Certified Public Accountants, the California Society of CPAs, and Financial Executives International.

Dr. Nataliya Agafonova, M.D., is the Chief Medical Officer at Longeveron. She previously served as clinical development lead, senior medical director, and product development chair at Otsuka Pharmaceuticals. Before that, she was the clinical development lead and senior medical director at Bristol-Myers Squibb. She previously held senior leadership positions at Ardea Bioscience, Biogen, Amgen, and Genzyme Corporation. She earned an M.D. from the Ukrainian National Medical University and completed her internal medicine residency at Kharkov State University Hospital in Ukraine.

Certain statements in this corporate profile that are not historical facts are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, which reflect management’s current expectations, assumptions, and estimates of future operations, performance and economic conditions, and involve risks and uncertainties that could cause actual results to differ materially from those anticipated by the statements made herein. Forward-looking statements are generally identifiable by the use of forward-looking terminology such as “believe,” “expects,” “may,” “looks to,” “will,” “should,” “plan,” “intend,” “on condition,” “target,” “see,” “potential,” “estimates,” “preliminary,” or “anticipates” or the negative thereof or comparable terminology, or by discussion of strategy or goals or other future events, circumstances, or effects. Factors that could cause actual results to differ materially from those expressed or implied in any forward-looking statements in this release include, but are not limited to, statements regarding the offer and sale of securities, the terms of the offering, about the ability of Longeveron’s clinical trials to demonstrate safety and efficacy of the Company’s product candidates, and other positive results; the timing and focus of the Company’s ongoing and future preclinical studies and clinical trials and the reporting of data from those studies and trials; the size of the market opportunity for the Company’s product candidates, including its estimates of the number of patients who suffer from the diseases being targeted; the success of competing therapies that are or may become available; the beneficial characteristics, safety, efficacy and therapeutic effects of the Company’s product candidates; the Company’s ability to obtain and maintain regulatory approval of its product candidates in the U.S., Japan and other jurisdictions; the Company’s plans relating to the further development of its product candidates, including additional disease states or indications it may pursue; the Company’s plans and ability to obtain or protect intellectual property rights, including extensions of existing patent terms where available and its ability to avoid infringing the intellectual property rights of others; the need to hire additional personnel and the Company’s ability to attract and retain such personnel; the Company’s estimates regarding expenses, future revenue, capital requirements and needs for additional financing; the Company’s need to raise additional capital, and the difficulties it may face in obtaining access to capital, and the dilutive impact it may have on its investors; the Company’s financial performance and ability to continue as a going concern, and the period over which it estimates its existing cash and cash equivalents will be sufficient to fund its future operating expenses and capital expenditure requirements. Additionally, Longeveron makes no assurance that any public offering of its securities as described herein will occur on the timelines, in the manner or on the terms anticipated due to numerous factors. Further information relating to factors that may impact the Company’s results and forward-looking statements are disclosed in the Company’s filings with the Securities and Exchange Commission, including Longeveron’s Annual Report on Form 10-K for the year ended December 31, 2022, filed with the Securities and Exchange Commission on March 14, 2023 and its Quarterly Report on Form 10-Q for the second quarter of 2023 filed with the SEC on August 11, 2023. The forward-looking statements contained in this corporate profile are made as of the date of this corporate profile, and the Company disclaims any intention or obligation, other than imposed by law, to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

Investor Contact
Mike Moyer
LifeSci Advisors
Tel: 617-308-4306
Email: mmoyer@lifesciadvisors.com

Date prepared: August 31, 2023

Longeveron Inc. (NASDAQ: LGVN), closed Monday's trading session at $0.6714, off by 16.075%, on 5,041,117 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.65/$4.40.

Recent News

Mullen Automotive Inc. (NASDAQ: MULN)

The QualityStocks Daily Newsletter would like to spotlight Mullen Automotive Inc. (MULN).

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle ("EV") manufacturer, has reached a commercial electric-vehicle milestone: its all-electric Class 3 low cab forward chassis truck has received certification from the California Air Resources Board ("CARB"), which means the vehicle meets specific emissions standards in compliance with CARB regulations. The certification means the vehicle qualifies for important state incentive programs, including an opportunity with California's Hybrid and Zero-Emission Truck and Bus Voucher Incentive Project ("HVIP") project. The HVIP project offers a rebate of up to $45,000 and, when combined with the $7,500 federal tax credit, totals a net effective cost of less than $20,000 for the Mullen THREE. California is one of 13 states, along with the District of Columbia, that have adopted Clean Air Act vehicle standards which require additional approvals beyond Environmental Protection Agency ("EPA") regulations. Mullen now has two vehicles — its Class 1 and Class 3 commercial vehicles — that have qualified for both EPA and CARB certifications. "CARB approval accelerates commercialization of the Mullen THREE and makes our vehicle even more appealing to customers who want to electrify their fleets," said Mullen Automotive CEO and chair David Michery in the press release. "Having both our Class 1 and Class 3 commercial EVs now CARB and EPA certified will continue to drive sales in all states across America."

To view the corresponding image, visit https://ibn.fm/4RpB2

To view the full press release, visit https://ibn.fm/jqH4t

Mullen Automotive Inc. (NASDAQ: MULN) is a Southern California-based automotive company that owns and partners with several synergistic businesses working toward the unified goal of creating clean and scalable energy solutions. Mullen has evolved over the past decade in sync with consumers and technology trends. Today, the company is working diligently to provide exciting EV options built entirely in the United States and made to fit perfectly into the American consumer’s life. Mullen strives to make EVs more accessible than ever by building an end-to-end ecosystem that takes care of all aspects of EV ownership.

Commencement of Trading on Nasdaq

On November 5, 2021, Mullen announced its commencement of trading on the Nasdaq Capital Market.

“Today is a monumental day for Mullen Automotive. I am especially proud of our team, investors and all who have believed in Mullen and taken us to this point as a publicly traded company on the Nasdaq Capital Market,” David Michery, CEO and Chairman of Mullen Automotive, stated in the news release. “Trading on Nasdaq now opens us up to new investors, both institutional and retail shareholders, and broadens our awareness and company profile, while increasing awareness of Mullen and our technology platform and opening new opportunities in EV and beyond. The road ahead has never been brighter for Mullen, and I am proud to lead us into the future.”

The milestone came in the wake of the company’s stock-for-stock merger with Net Element Inc.

The Mullen FIVE

The Mullen FIVE EV Crossover, debuting at the Los Angeles International Auto Show (LAIAS) on November 17, 2021, embodies Mullen’s Southern California roots with an inspired design focused on two complementary Golden State themes – California landscape and California urban.

The FIVE is built on an EV Crossover skateboard platform that offers multiple powertrain configurations and trim levels in a svelte design that is Strikingly Different™ and exciting to experience in person.

Prior to the start of LAIAS, the Mullen FIVE was selected as a finalist by the LA Auto Show for Top EV SUV in the ZEVA “People’s Choice” Awards.

LAIAS provides Mullen an opportunity to display multiple variants of the FIVE model while also showcasing its powertrain, battery and charging technology. The company intends to bring the FIVE to market in 2024, and reservations are currently open here.

Mullen’s development portfolio also includes EV Fleet Vans, which it intends to bring to market in Q2 2022, and the pure electric, high performance Mullen DragonFLY.

Expansion of Manufacturing Capacity

On November 2, 2021, Mullen announced plans to expand its facility in Robinsonville, Mississippi.

Mullen’s Advanced Manufacturing and Engineering Facility (AMEC) currently occupies 124,000 square feet of manufacturing space. The total available land on the property is over 100 acres, and Mullen is moving ahead with plans to build out another 1.2 million square feet of manufacturing space to support class 1 and class 2 EV cargo vans and the Mullen FIVE EV Crossover.

On the expanded site, Mullen plans to build a body shop, a fully automated paint shop and a general assembly shop.

EV Market Outlook

The global EV market was reported to consist of 3,269,671 units in 2019, a figure that is expected to grow at a CAGR of 21.1% through 2030 to a total of 26,951,318 units worldwide. This market’s monetary value was estimated at $162.34 billion in 2019 and is expected to grow at a CAGR of 22.6%, resulting in an approximate value of $802.81 billion by 2027. The primary driver for this exponential growth is a worldwide increase in vehicle emissions regulations.

Management Team

David Michery is the CEO and Founder of Mullen and has been leading the company and its divisions since inception in 2014. With over 25 years of executive management, marketing, distressed assets, and business restructuring experience, Mr. Michery brings a wealth of relevant knowledge and expertise to the Mullen brand. He has notably created 12 trademarks so far to develop the company brand and vision.

Mr. Michery is working toward a sustainable future accessible to all by creating a suite of clean-energy electric vehicles at varied price points. With entirely U.S.-based manufacturing and operations, he is also determined to have Mullen Technologies play a role in shaping a self-sustaining local economy by creating more jobs in America.

Mr. Michery manages risks and company expectations as a pathway to success and has personally overseen several businesses that totaled over $1 billion in transactions. His key strength is the ability to be fiscally responsible and lead teams to complete projects on time and within budget. As a seasoned professional in this space, Mr. Michery has demonstrated skill in building businesses from the ground up and into successful entities that subsequently sold for hundreds of millions of dollars.

Mullen Automotive Inc. (MULN), closed Monday's trading session at $7.79, up 16.6168%, on 1,356,526 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $6.36/$10080.00.

Recent News

Horizon Fintex | Upstream

The QualityStocks Daily Newsletter would like to spotlight Horizon Fintex | Upstream

A recent blog written by Fernanda De La Torre highlights opportunities in the future of trading with spot bitcoin exchange-traded-funds ("ETFs") and the capabilities of Upstream's app.

"Following the SEC's recent approval of the first U.S.-listed bitcoin ETFs on Jan. 10, 2024, aimed at tracking bitcoin's performance, Upstream is excited to announce that we are accepting applications for bitcoin ETFs to list on our global market," De La Torre writes. "Upstream, a regulated MERJ exchange market and global trading app, is actively accepting applications for bitcoin ETFs to list, giving applicants access to a global, digital-first investor base to access their ETF shares from anywhere using a trading app."

"Just as bitcoin ETFs aim to provide streamlined access to crypto for investors, Upstream strives to offer investors streamlined access to securities from exchanges worldwide. Upstream is designed to remove the barriers typically involved when opening a digital wallet. Users can simply download Upstream, create a password, which in turn establishes a digital wallet on the backend. All blockchain technology and digital wallet creation occur under the hood. Bitcoin ETFs are unlocking a whole new pool of investors. We believe Upstream can push that further, with its market being powered by the same technology that gives digital currencies their value."

To view the full blog, visit https://ibn.fm/yA8Ru

Horizon Fintex is a software business specializing in compliant securities solutions. The company aims to facilitate the future of capital markets by leveraging the regulatory experience of Wall Street bankers and the proven track record of technology veterans to bring focus to compliance, efficiency, security and transparency.

Horizon’s flagship product is the revolutionary trading app ‘Upstream’, a MERJ Exchange Market, and the first regulated market powered by a blockchain to offer both digital securities and NFT trading. Upstream traders experience T+0 settlement, best bids and offers displayed on a transparent public orderbook that prevents predatory market practices – all from a user-friendly trading app.

Products

Horizon Fintex offers a full suite of end-to-end blockchain-enhanced software solutions to create a seamless experience for both issuers and investors. Its product suite includes:

  • Securitization & Issuance – ETSware is an end-to-end Electronic Trading System streamlining capital raising from primary issuance through compliant secondary trading.
  • KYC Compliance Onboarding – KYCware is a white label Know Your Customer (KYC) and Anti-Money Laundering (AML) compliance software solution offering best-in-class cryptographic security to compliantly onboard and verify user identity through a smartphone application.
  • AML Screening Software – AMLCop offers advanced Anti-Money Laundering (AML) software to streamline the verification of user details against a proprietary database of global sanctions, politically exposed persons (PEPs) and watchlists.
  • Cap. Table Management Tools – CustodyWare equips registered U.S. transfer agents with next-generation cap. table management software to manage securities on behalf of their clients pursuant to an SEC-registered or exempt securities offering.
  • Exchange & Trading App Technology – Open Order Book offers Ethereum blockchain securities exchange software to power the next generation of trading venues for digital assets.

Upstream – The Horizon-Powered Trading App

Upstream is a joint venture with MERJ Exchange (merj.exchange), an affiliate of the World Federation of Exchanges.

Upstream aims to be the premiere global trading hub offering issuers around the world exposure to a digital-first investor base that can trade using USDC digital currency along with credit, debit, PayPal, and USD (fiat) to increase liquidity and enhance price discovery; while also offering investors access to dual-listed companies, IPOs, crowdfunded companies, U.S. & Int’l. equities, digital coupons and NFTs directly from a user-friendly trading app.

Upstream aims to unlock liquidity for investors of all levels while offering industry-leading levels of transparency, accessibility and investor protections enforced using Ethereum blockchain technology.

Management Team

Brian Collins is the CEO of Horizon Fintex. He founded the company in 2010. From 1999-2010, Mr. Collins was CEO of Abbey Technology in Switzerland, specializing in the design of trading software for Swiss banks. Prior to this, he worked for Credit Suisse in Zürich, designing and building proprietary equity trading solutions. Mr. Collins graduated in 1990 with a BS in Computer Systems from the University of Limerick, Ireland.

Mark Elenowitz is the company’s President. He is a Wall Street veteran with over 29 years of experience. Mr. Elenowitz was the co-founder of a U.S. broker dealer and is Managing Director of two U.S. broker dealers, responsible for advising clients on compliance, capital structure and capital market navigation. He was responsible for leading the first successful Reg A+ IPO of a company to list on the NYSE and others which listed directly onto Nasdaq. He is a noted speaker at Small Cap and Reg A events, including the SEC Small Business Forum, and has been profiled in BusinessWeek and CNBC, as well as several other publications. Mr. Elenowitz is a graduate of the University of Maryland School of Business and Management with a BS in Finance and holds Series 24, 62, 63, 79, 82 and 99 licenses.

Dr. Andrew Le Gear is the CTO of Horizon Fintex. Prior to joining the company in 2013, he worked as a software engineer with Dell Inc. (2012-2013) and Lehman Brothers and Nomura Plc. (2007-2012). Dr. Le Gear was a co-founder of Juneberi Ltd., a research-driven software tech start-up (2004-2007). He graduated in 2006 with a Ph.D. in Computer Science from the University of Limerick, Ireland.

Peter Hall is the company’s CIO. Prior to joining Horizon Fintex in 2011, he worked at Microsoft (2008-2011), Atos Origin (2004-2008) and AIT Group Plc. (1998-2002). Mr. Hall has held CISSP certification since 2010. He graduated from the University of Sheffield, UK in 1995 and earned an MS from the University College London in 2006.

Mike Boswell is the CFO of Horizon Fintex. A Wall Street veteran, he co-founded a U.S. broker dealer and served as Chief Compliance Officer. Mr. Boswell was also Managing Director of TriPoint Capital Advisors, a merchant banking and financial consulting company, and CFO of Mission Solutions Group, a privately held defense sector firm. He earned an MBA from John Hopkins University and a BS in Mechanical Engineering from the University of Maryland. Mr. Boswell holds Series 24, 62, 63, 79, 82 and 99 licenses.

Recent News

chart

SenesTech Inc. (NASDAQ: SNES)

The QualityStocks Daily Newsletter would like to spotlight SenesTech Inc. (NASDAQ: SNES).

SenesTech (NASDAQ: SNES), the leader in fertility control to manage animal-pest populations, has entered a signed distribution agreement with Poppe Enterprises LLC. A distributor and pest-management company focused on the grain-management market, Poppe Enterprises serves Nebraska, South Dakota, North Dakota, Kansas, Wyoming, Iowa and Colorado. Poppe Enterprises will be a stocking distributor for SNES's Evolve(TM) soft bait and has placed an initial stocking order. Evolve is designed to address the fundamental issue of rodent overpopulation by focusing on the rapid reproduction of rats; the product controls the population by reducing or eliminating the fertility of rats, rather than trying to keep up with the growing numbers of an infestation with poisons alone. "Grain-storage operations have unique challenges when it comes to rodent pest control," said SenesTech president and CEO Joel Fruendt in the press release. "Poisons are highly regulated and are tricky to use without contamination, and traps are expensive and time consuming to maintain. The nonpoison Evolve soft bait, with its minimum risk EPA designation, reasonable cost, and proven efficacy, provides a new tool for this widespread market. We are partnering with a leader and innovator in grain management and pest control, Poppe Enterprises. Poppe Enterprises has a keen focus on innovation, safety and sustainability, and a strong reputation in this substantial market. Their presence and market knowledge will mean immediate penetration of the Evolve product."

To view the full press release, visit https://ibn.fm/JZ6Ot

SenesTech Inc. (NASDAQ: SNES) is the rodent fertility control expert and the inventor of the only EPA-registered contraceptive for male and female rats. The company’s technology provides an innovative and humane method for managing rat populations.

SenesTech is focused on developing effective solutions that are grounded in science and proven through research, all while providing value to people, communities and the environment. The company’s passion is to create a healthier world by better controlling rat pest populations. This aim is critical, as, if left unchecked, a breeding pair of rats and their descendants can produce up to 15,000 pups after just one year.

The company strives for clean cities, efficient businesses and happy households – with a product that was scientifically designed to be effective without killing rats. SenesTech is committed to the sustainable, humane treatment of animals, improving the quality of all human life and enhancing environmental stewardship through the global application of its effective solution in fertility control technology.

SenesTech is headquartered in Phoenix, Arizona.

ContraPest®

SenesTech’s first product, ContraPest®, applies revolutionary technology to a global challenge that has persisted since the Middle Ages – the proliferation of rats in urban and agricultural settings. ContraPest® targets the reproductive capabilities of Norway and roof rats. As a highly palatable liquid, the formulation promotes sustained consumption, helping to reduce fertility in both male and female rats, bringing populations down and keeping them down.

The company’s flagship offering can be used as part of integrated pest management (IPM) programs – fitting seamlessly into all IPM programs – to help reduce reproduction and magnify the success of these protocols, or as a standalone solution for customers who want to reduce or eliminate the use of lethal rodent control methods.

In multiple, independent field deployments, ContraPest was shown to reduce rat activity over 90% when added to an existing IPM program.

ContraPest® is registered federally as a General Use Product.

Delivery Systems and New Products

In July 2023, SenesTech began to distribute a new delivery system for ContraPest®, the Isolate Bait System™. This new delivery system brings to market a simple design that enables more efficient deployment, incorporates an enhanced formulation of ContraPest® that is expected to provide improved performance of the fertility control bait in the field and is paired with a new bait station that is more space-efficient and economical.

The other delivery systems available for ContraPest include the Ultimate Bait System™, a tank and tray in a larger format for use with more severe infestations, and the Elevate Bait System™, a unique delivery system that targets above ground infestations, as with roof rats.

SenesTech, as of August 2023, is also in the final stages of releasing a soft bait formulation, which provides the unique attributes of proven fertility control in an industry-familiar format demanded by big box retailers, key e-commerce channels and leading industry pest management professionals.

Market Opportunity

According to SenesTech’s figures, rats cause over $27 billion in damage to public and private infrastructure annually in the United States. Rats also destroy 20% of the global stored food supply every year by consuming or contaminating it.

Rats are known to spread at least 35 diseases, globally posing a dangerous risk to public health and safety. Not only does this age-old problem persist despite extensive campaigns to eradicate it, but multiple sources have reported that post-COVID rat populations have boomed.

Poison-based control methods sicken rats, and they typically die slowly. An animal that eats a poisoned rat may also sicken or die. The global rodenticide market is projected to be worth $1.7 billion by 2026.

In one case study, results reported by the customer showed a $5,000 investment in ContraPest® saved more than $500,000 annually in reduced labor, loss and damage.

Management Team

Joel Fruendt is SenesTech’s President and CEO. He has 15 years of executive leadership in the vector and pest control industries as Vice President and General Manager of Clarke Environmental Inc., a leading vector and pest control products and services company. He has extensive expertise in the development and manufacturing of EPA-registered chemical control products, and the commercialization and sale of those products. He received the ‘Smart Leaders’ award from Smart Business Magazine and holds a bachelor’s degree in business from Illinois Wesleyan University.

Tom Chesterman is CFO at SenesTech. He has over 20 years of experience as the CFO of public companies in the life science, tech and telecommunications industries. Most recently, he was the Vice President and Treasurer of GCI, a telecommunications company. Previous to that, he was the CFO of life science companies Bio-Rad Laboratories, Aradigm and Bionovo. He has a bachelor’s degree from Harvard University and an MBA from the University of California at Davis.

Dan Palasky is Chief Technical Officer at SenesTech. Previously he held the title of Vice President of Research & Development at PLZ Corp., a manufacturer of chemical consumer products, serving as the technical expert for its entire product portfolio. He started his career with Camie-Campbell, Inc., as a chemist in the R&D department. Mr. Palasky received his bachelor’s degree in chemical engineering from the Missouri University of Science & Technology and his MBA in Project Management from Aspen University.

SenesTech Inc. (NASDAQ: SNES), closed Monday's trading session at $0.84, up 7.5544%, on 233,131 volume. The average volume for the last 3 months is 2.28M and the stock's 52-week low/high is $0.52/$80.952.

Recent News

Reunion Gold Corp. (TSX.V: RGD) (OTCQX: RGDFF)

The QualityStocks Daily Newsletter would like to spotlight Reunion Gold Corp. (TSX.V: RGD) (OTCQX: RGDFF) .

Reunion Gold Corp. (TSX.V: RGD) (OTCQX: RGDFF) is a leading gold explorer in the Guiana Shield, South America. In early 2021, the Company announced an exciting new greenfield gold discovery at its Oko West project in Guyana, where, after 22 months of resource definition drilling, the Company has announced an initial Mineral Resource Estimate (MRE) containing 2.475 Moz of gold in Indicated resources at 1.84 g/t and 1.762 Moz of gold in inferred resources at 2.02 g/t contained within a pit shell outline. Preliminary metallurgy results performed by the company, consisting of 8 bottle roll tests obtained strong results, averaging just under 90% recoveries on average. The Company is continuing with additional development activities at Oko West, including environmental base line studies and additional metallurgical work relating to the delivery of a PEA by year end 2023. In addition, Reunion Gold is currently exploring several priority targets in the Oko West project area on which the company feels there is good potential to add additional resource ounces. This includes the opportunity to grow the initial mineral resource estimate (MRE) released on June 13, 2023, and to discover additional gold ounces at Oko West outside of the resource area.

The Guiana Shield remains one of the most prospective exploration locations globally for the discovery of world class orogenic gold deposits. The shield, including both Guyana and Surinam, contain large relatively underexplored greenstone belts, from which Reunion Gold expects many more significant gold discoveries could emerge in the coming years.

Oko West Project

Reunion Gold’s Oko West Project is a brand-new gold discovery in northwest Guyana located within the historical Oko gold district. Alluvial gold has been mined from the Oko district since the turn of the century, but very little primary gold has been mined or even explored for to the best of the company’s knowledge. The project comprises a prospecting license with an area of approximately 44 square kilometers and is 100% held by Reunion’s Guyanese subsidiary.

In 2020, Reunion Gold’s geochemical survey, trenching and initial 1000 m drill program discovered and confirmed the presence of gold mineralization in this Orogenic gold system. The gold occurs in the eastern edge of the project area, along a 6km long sheared contact between a granitoid intrusion and a meta volcanic-meta sedimentary rock package. The MRE is located within the Kairuni zone, which represents the northern most 1.9 km of the 6 km long contact.

“We are advancing our Oko West project along two tracks. The first is to advance the exploration programs outside of the Kairuni zone, aimed at outlining and discovering additional gold mineralization within our Prospecting License. On this front, I am very excited by the results from the initial Scout RC Geochem drill program that is defining new targets west of our Kairuni zone,” Rick Howes, President and CEO of Reunion Gold, stated in a recent news release. In addition to the targets west of the Kairuni zone, the company has also commenced exploration work on the southern ~ 4 km of the same sheared contact that hosts the Kairuni zone MRE. In addition, the company feels that the MRE marks the size of the Kairuni resource at a point in time and that there is good potential to continue to grow the resource. The MRE remains open at depth below the resource pit outline in the block 4 area and also to depth and along strike in the block 5 and 6 areas. In addition to the exploration programs, the second strategic track is to rapidly advance the Kairuni zone along the path to development. To that end the company is moving forward with the engineering and other studies, including more detailed metallurgical studies, that will support the release a PEA on the Kairuni zone by year end 2023 The company feels that the rapid advancement of development of Kairuni zone MRE, while in parallel continuing to explore for additional ounces on the project, is the best path to try and maximize shareholder value in the shortest period of time.

Guyana

Guyana boasts a long history of mining gold, bauxite, diamonds and manganese. Still, the greenstone belts of the Guiana Shield remain relatively unexplored when compared to the analogous regions of the West African Shield (Birimian), which, according to geological evidence, was once connected to the Guiana Shield, forming a contiguous craton prior to the Mesozoic period.

Despite a historical lack of accessibility and low exploration intensity, several significant large-scale projects have emerged in the Guiana Shield, including Aurora, Oko West, Oko Main, Toroparu and Omai. Guyana is English speaking with a British based parliamentary and legal system and boasts the world’s fastest growing economy on the back of significant offshore oil discoveries by Exxon and its partners. It is expected that a significant amount of the revenues from oil production will be invested in improving the infrastructure, education and health care and agriculture within the country.

Market Opportunity

The World Gold Council, an industry association representing gold producers with hundreds of mining operations in nearly 50 countries around the world, called 2022 the “strongest year for gold demand in over a decade.” Annual gold demand jumped 18% YoY due to “colossal central bank purchases, aided by vigorous retail investor buying and slower ETF outflows.”

Despite this spike in demand, total annual gold supply increased by just 2% in 2022, halting two years of successive declines but failing to challenge 2018 highs. This supply-demand imbalance could provide a favorable market environment as Reunion Gold continues to advance drilling programs at its 100%-owned Oko West Project.

Management Team

Successful exploration and the discovery of significant deposits in any given region require immense amounts of local knowledge and experience. This is the principle around which Reunion Gold has built its management team. In total, the company’s leadership boasts over 225 years of combined experience in the Guiana Shield.

David Fennell is the Executive Chairman of Reunion Gold, a position he has held since the company’s inception in 2003. He has 40 years of experience in the mining industry. He received a law degree from the University of Alberta in 1979 and practiced law until he founded Golden Star Resources Ltd. in 1983. During his term as President and CEO, Golden Star became one of the largest and most successful exploration companies. While at Golden Star, he was instrumental in the discovery and development of the Omai Gold Mine in Guyana and the Gross Rosebel Mine in Suriname. In 1998, Mr. Fennell became Chairman and CEO of Hope Bay Gold Corporation. He held this position through the merger of Hope Bay and Miramar Mining Corporation and remained as Executive Vice-Chairman and Director for the combined entity until its takeover by Newmont Mining Corporation in 2008. Mr. Fennell is currently a member of the board of directors of G Mining Ventures Corp. and Sabina Gold & Silver Corp.

Rick Howes, P.Eng., is the company’s President and CEO. He is a seasoned mining executive with over 39 years of experience in the mining industry, most recently as CEO of Dundee Precious Metals. Mr. Howes has extensive operating, technical and project development experience in both underground and open pit mines throughout Canada and internationally. In 2009, Mr. Howes joined Dundee Precious Metals, where, as VP and General Manager, he led the transformation of the Chelopech Mine in Bulgaria to reach world-class levels of performance. He became COO in 2011 and oversaw several significant growth capital development projects, including the expansion of the Chelopech Mine, the upgrade and expansion of the Tsumeb Smelter in Namibia and the development of the greenfield Ada Tepe open pit gold mine in Bulgaria. He was appointed CEO in April 2013, leading Dundee’s transformation from a junior gold producer to a multi-asset mid-tier gold producer generating strong free cashflow and solid returns to shareholders. Mr. Howes has been recognized as a visionary leader in mining, organizational innovation and transformation and was recognized as the Outstanding Innovator of 2016 by the International Mining Technology Hall of Fame.

Alain Krushnisky is the CFO of Reunion Gold. He brings to the company years of experience in the mining sector, including 10 years with Cambior Inc. (now IAMGOLD) in capacities such as Vice-President and Controller. Since 2004, Mr. Krushnisky has been doing consulting work for various publicly listed exploration and mining companies. He graduated from the University of Ottawa in 1983 with a bachelor’s degree in commerce and is a Chartered Professional Accountant.

Justin van der Toorn is the company’s VP Exploration. He is an exploration geologist with 18 years’ experience in the minerals industry, leading and managing exploration teams from grassroots activities through to discovery and resource definition drilling. Mr. van der Toorn’s previous experience has been in a range of commodity and deposit styles, including extensive work in Carlin-style gold, low- and high-sulphidation epithermal, porphyry and orogenic gold systems. He holds an MSci degree in Geological Sciences from the Royal School of Mines, Imperial College London. He is registered as a Chartered Geologist (CGeol) of the Geological Society, and a European Geologist (EurGeol) by the European Federation of Geologists.

Doug Flegg is the company’s business Development advisor. Doug has over 35 years’ experience in mining and mining finance with senior positions in research, portfolio management and global equity sales. Previously, Mr. Flegg was Managing Director Global Mining Sales with BMO Capital Markets where he was involved in raising $35 billion in over 200 corporate financings. Since 2016 he has been providing business development, strategic, and financing advice to corporate mining clients. Mr. Flegg also has a B.Sc. in Geology, work experience as a geologist and an MBA from Queens University.

Reunion Gold Corp. (OTCQX: RGDFF), closed Monday's trading session at $0.28, even for the day. The average volume for the last 3 months is 139,842 and the stock's 52-week low/high is $0.2123/$0.46.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower
ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers

QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower
ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers

QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower
ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

370 N. Hayden Rd.
Suite 123-591
Scottsdale, AZ 85251
480-374-1336

Please read Disclaimers for FULL Compensation Disclosures and other disclaimers.

Copyright © .